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Abstract
Previous research has suggested that looking at a painful body part has an analgesic
effect on experimental pain. Furthermore, it has been demonstrated that magnifying
the size of the viewed part has a greater analgesic effect, while minifying the
perceived size of the body part reduces the analgesia. These studies involved the
application of a noxious stimulus to the skin, inducing pain that is perceived
superficially. It is believed that most clinical pain is likely contributed to by noxious
information from deep tissues and is certainly more commonly perceived as deep
(below the skin surface). Research on clinical populations has also supported the idea
that visualisation of the painful body part is analgesic, however the effects of
magnification and minification are opposite to those seen with an experimental pain
paradigm. While a number of mechanisms might explain these differences it is
possible that the modulatory effect of vision is different for pain that is perceived
superficially to that which is perceived deeply.
Here we explore the effects of visualisation and visual enlargement on experimental
deep tissue pain of the anterior thigh. All participants undertook a bout of high load
eccentric exercise to induce delayed onset muscle soreness. Twenty four hours later
those participants who reported at least a moderate level of muscle soreness were
tested in a four phase randomised cross-over experiment. We measured pain
intensity during the performance of a standardised quadriceps contraction under
four different visual conditions, namely: normal visualisation of the thigh; magnified
visualisation of the thigh; visualisation of the contralateral uninjured thigh and
visualisation of a neutral object. Contrary to previous research on superficially
perceived pain, we found no difference in pain intensity across any of the four
conditions. These results demonstrate that visualisation does not have an analgesic
effect on experimental deep tissue pain, suggesting that different modulatory factors
exist for superficial and deep experimental pain. It also proposes the notion that
visualisation may only have a modulatory effect on experimental pain when visual
feedback offers a significant contribution to the perception of safety of the
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stimulated structure. Visualisation provides clear information that all is well with the
skin but less credible evidence that all is well with deep structures, however this
hypothesis remains to be tested.
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CHAPTER ONE: INTRODUCTION

1.1

Topic and Purpose

Chronic pain has a debilitating impact not just on the lives of the sufferers, but also
on the broader Australian community. It is one of Australia’s most widespread health
issues, costing the economy over $34.3 billion annually (MBFFoundation, 2007). In
2003, the medical cost of managing lower back pain alone in Australia was $A 1.02
billion, which was relatively insignificant compared to the societal cost of $A 8.5
billion (Walker, Muller, & Grant, 2003). Chronic pain affects almost one in three
Australians (Blyth et al., 2001) and is often accompanied by mental disorders such as
depression, anxiety and suicide attempts (Twillman, 2007). Although our
understanding of pain is constantly evolving and improving, much remains unknown
regarding pain mechanisms, particularly the host of factors which interact to
modulate the perceived pain experience. As a result the effects of most common
treatments are modest and the burden of pain continues to escalate.
To date, several experiments have investigated the modulatory effect of visualisation
on pain using a paradigm of delivering noxious stimulation to the skin (Diers et al.,
2013; Longo, Betti, Aglioti, & Haggard, 2009; Mancini, Longo, Kammers, & Haggard,
2011; Osumi et al., 2014) . These studies have helped to indicate the potential
analgesic effect of visualisation and to suggest strategies that might be useful in the
management of clinical pain (Diers, Loffler, Zieglgansberger, & Trojan, 2015; Wand et
al., 2012). However, there are a number of important differences between pain
arising from experimental stimulation of the skin and clinical pain. One distinction is
that it is thought that noxious information arising from deep tissues make a more
significant contribution to the emergent pain experience than noxious information
from the skin (Bove, Zaheen, & Bajwa, 2005). One important step in determining if
visualisation evoked analgesia might be a useful clinical tool is to investigate if the
phenomenon holds true for pain evoked from noxious deep tissue stimulation.
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This study is novel in that it will explore experimental pain mediated by input from
deep tissues, in particular to see whether factors which have been shown to have
modulatory effects on pain evoked by superficial tissue stimulation influence pain
evoked by deep tissue stimulation in the same way. Firstly, it will investigate whether
visualisation of the painful body part affects the perceived intensity of pain. Secondly,
it will attempt to establish whether visual magnification of the body part has any
further effect on the perceived pain level, as has been demonstrated in superficial
experimental pain.
The primary purpose of this study is to establish whether vision and visual
magnification modulate pain perception and in so doing to better understand the
mechanisms modulating pain perception when deep tissues are nociceptively
activated, as these may assist our approaches to management of clinical pain states.
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1.2

Background

Traditionally the experience of pain was believed to be synonymous with nociception.
Pain was regarded as a linear sensory experience dependant only on A Delta and C
nociceptive fibres transmitting impulses to a “pain” centre in the brain (Melzack,
1996), that is pain was thought to reside within the peripheral tissues and blocking
nociception was seen as the fundamental therapeutic approach. Over the last four
decades our understanding of pain has been revolutionised, with nociception now
seen as only one component of the emergent pain experience. Indeed it is now clear
than nociception is neither necessary nor sufficient for the production of pain. Pain
does not exist within the tissues but is created by the brain (Moseley, 2007).
Pain emerges into consciousness when the brain decides that the body’s tissues are
under threat and action is required (Moseley & Flor, 2012). This involves the
processing, scrutinising and modulation of multiple information sources at a number
of levels throughout the neuraxis (Moseley, 2007) and importantly emphasises that
the management of pain has multiple targets. Essentially, anything that decreases
the individual’s perception of danger to the tissues has the potential to moderate the
pain experience. The multi-sensory emergent nature of pain is highlighted by recent
work demonstrating the importance of visual input on modulating the pain
experience.
Longo et al. (2009) showed in healthy volunteers that observation of the body part
while an unseen painful stimulus is applied topically to that body part has an analgesic
effect compared to observation of a neutral object. They adopted the term “noninformative analgesia” as the stimulus is not visualised, ruling out the opportunity of
attributing the analgesic effect to the observation of the agent responsible for
noxious stimulation. Similar results were observed by Diers et al. (2013) in a chronic
back pain population. Visual feedback of the patients’ own backs reduced the
perceived intensity of experimentally induced pain. Diers et al. (2015) expanded the
concept of visual analgesia by observing it in a chronic back pain population, in this
case demonstrating that the intensity and unpleasantness of the subjects’ habitual
3

perceived back pain could be reduced by subjects watching their back on a video
screen.
However, the effect of visualisation on perceived pain is not yet beyond doubt.
Subsequent to the design of our study, research with contrasting results has
emerged. Valentini, Koch, and Aglioti (2015) recorded an analgesic effect only when
viewing the hand was combined with the hand crossing the midline. No analgesia was
experienced with visualisation alone. Torta, Legrain, and Mouraux (2015) did not
observe visual analgesia at all either when subjects viewed a mirror image of their
hand or when they viewed their hand directly. Clearly more work is needed to explore
the effect of visualisation on pain intensity.
The effects of visual distortion of body size on pain perception have also been
explored. Mancini et al. (2011) proposed a dose-response relationship to visual
analgesia. With magnification of the perceived size of the body part an increased
analgesic effect was observed whereas minification of the body part reduced the
analgesic effect.
Subsequent to these findings Osumi et al. (2014) suggested that an analgesic effect
to a magnified view of the body part is not necessarily a standard response. Exploring
possible factors associated with modulation of pain by visual distortion of size, Osumi
et al. (2014) used a mirror to reflect and augment the size of the viewed hand while
applying a topical noxious heat stimulus to the unviewed hand. Subjects who
exhibited a higher pain threshold under the enlarged hand condition were also found
to experience more vivid somatosensory perception and reported that they felt
“nothing special” in response to the view of the enlarged limb. The subjects who
demonstrated a lower pain threshold under the enlarged condition did not show any
significant difference in two-point discrimination and responded that they felt
unpleasant emotions towards the view of the enlarged hand. This study suggests that
specific factors are associated with modulation by visualisation and visual distortion
of size. Their study introduces some of these factors however investigation to explore
further conditions for an effect by visualisation is warranted.
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In contrast to the positive effects of magnification observed by Mancini et al. (2011),
Moseley, Parsons, and Spence (2008) demonstrated an augmented pain response to
a magnified view of the upper limb in the case of chronic regional pain syndrome
(CRPS) patients and an analgesic response to the minified view of the limb.
Ramachandran, Brang, and McGeoch (2009) found a similar analgesic response to
minification of the reflection of the intact limb (which was perceived as the phantom
limb) in a patient with phantom limb pain.
The studies by Longo et al. (2009), Mancini et al. (2011), Diers et al. (2013) and Osumi
et al. (2014) involved the application of noxious stimuli to the skin of subjects. We
still know relatively little about modulatory factors influencing clinical pain states and
whether the findings of studies involving experimental topical noxious stimuli can be
extrapolated to the clinical environment. There are a number of important
differences between pain arising from noxious stimuli applied to the skin and pain
arising from noxious stimuli from deeper tissues. One distinction is that it is thought
that noxious information arising from deep tissues make a more significant
contribution to the emergent pain experience in clinical pain states than noxious
information from the skin (Bove et al., 2005). An important step in determining if
visual analgesia might be a useful clinical tool is to investigate if the phenomenon
holds true for pain evoked from experimental deep tissue stimulation. A better
understanding of deep tissue pain could potentially assist us to target treatment of
chronic pain conditions more appropriately.
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1.3

Development of this Research Study

In the previously-mentioned experimental studies, pain has been induced through
topically applied noxious input. The resultant superficially felt pain is potentially very
different to clinical pain for a number of reasons, one of which is that clinical pain is
thought to be more commonly associated with noxious input from deeper structures.
This study was developed with a view to generate deep tissue pain in normal subjects’
quadriceps muscles by inducing delayed onset muscle soreness (DOMS), and then to
investigate the effects of visualisation and visual distortion of size, in the form of
magnification, on pain perception. An experimental healthy population was used in
order to minimise extraneous influences that clinical states introduce.
Many of the experimental studies which have demonstrated the existence of visual
analgesia and analgesic responses to visual distortion of body size have made use of
mirror boxes to allow for “non-informative” noxious stimulation (Longo et al., 2009)
and for manipulation of perceived size of the limb. It has recently been suggested
that use of the mirror box may induce an analgesic effect rather than the visualisation
component of these experiments per se. The proposed mechanism underlying this
mirror-box analgesia may involve a degree of conflict (introduced by the mirror)
between a subject’s proprioceptive, somatosensory and visual representations
(Torta et al., 2015), the added attentional processes that embodiment of the
reflected image might entail or simply the greater novelty of viewing a reflected
image. In light of this possibility, we used magnifying glasses to visually distort the
view of the limb rather than concave and convex mirrors positioned on a mirror-box.
This excluded the possibility of the reflected image contributing to “visual analgesia”.
Given the ambiguity of previous findings and the lack of visualisation-analgesia
studies in deep tissue our hypotheses were:
1. Visualisation of the painful body part will have an effect on deep tissue pain
2. Pain perception will be modified by visual distortion of the size of the viewed
quadriceps muscle, in the form of magnification.
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As part of our study we included the use of the short version of the Pain Anxiety
Symptom Scale (PASS-20) (Appendix 1) and the Pain Sensitivity Questionnaire (PSQ)
(Appendix 2). These have both been shown to be reliable predictors for the
development of chronic pain (Lance M. McCracken & Dhingra, 2002; Ruscheweyh,
Marziniak, Stumpenhorst, Reinholz, & Knecht, 2009). The researchers felt it would be
worthwhile to explore for any interaction between pain anxiety, trait sensitivity and
pain during the various visual conditions. Modifying the subjects’ view of their thigh,
particularly in the case where the view of the thigh was obstructed by a neutral
object, had the potential to affect their anxiety levels and this in turn could have had
some impact on their perceived pain levels.
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1.4

Potential Significance

Recent research results indicate that visualisation can potentially modulate pain
perception and furthermore visual distortion of body size can further modify the pain
experience. However, the direction of the effect is at this stage disputed, as
contrasting findings have been observed both within experimental conditions
involving superficial pain and in clinical populations. This study attempted to establish
whether visualisation of the painful body part has an effect on experimental deep
tissue pain, and if so, whether this was in the direction of analgesia. Secondly, this
study explored whether visual distortion of body size impacts pain perception,
specifically magnification of the viewed body part. Exploration of deep tissue pain is
necessary as most clinical pain is believed to involve noxious input from tissues
deeper than the skin. The results of this study could form the basis for future therapy
targeting chronic deep tissue pain; that of manipulating multisensory input (such as
vision) to modulate the pain experience.
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CHAPTER TWO: LITERATURE REVIEW

2.1

Past Concepts of Pain

Until the 1960’s, pain was believed to be a specific sensory modality, comprising
peripheral receptors and unique, afferent neural pathways, terminating in a distinct
centre in the brain. It was paralleled to modalities such as vision or hearing.
Nociceptors were thought to detect noxious stimuli in the periphery and convey
impulses, to the “pain centre” in the brain. The intensity of perceived pain was
thought to reflect only the extent of tissue damage in the periphery (Melzack, 1996)
and the blocking of nociception was seen as the primary therapeutic approach.
In 1965 Melzack and Wall started to question the traditional linear concept of pain as
it did not explain complex pain phenomena such as causalgia. They presented the
Gate Control Theory, a theory that small fibre nociceptive pathways responsible for
signalling pain (C fibres) were inhibited by concomitant large fibre inputs signalling
touch or other modalities (Aβ). Nociception was believed to be modulated
peripherally at a spinal level, before ascending to evoke the perception of pain
(Melzack, 1996). This was one of the first concepts proposing modulation of pain, and
led to further investigation of this phenomenon.
Over the past four decades, our concepts of mechanisms underlying pain have
evolved radically to the point where we now believe pain to be a complex interaction
of multiple inputs creating a subjective, multidimensional, emergent experience
(Grieve & Schultewolter, 2014). This complex perception is reflected in the current
definition of pain provided by the International Association for the Study of Pain
(IASP): “An unpleasant sensory and emotional experience associated with actual or
potential tissue damage, or described in terms of such damage” (Merskey & Bogduk,
2012).

9

2.2

The Neuroanatomical Pathways of Nociception
2.2.1 Peripheral nociception.

Peripheral sensory nerves are responsible for conveying afferent signals to the spinal
cord and ultimately the brain thus allowing for a conscious perception of the
peripheral event that is taking place (van Griensven, 2005). Receptors transduce
stimuli allowing transmission of a signal along the afferent fibre. These receptors can
be specialized responding only to a specific stimulus, or they can be polymodal
responding to various types of stimuli. Mechanoreceptos are sensitive only to
mechanical stimulation such as pressure, touch, vibration etc. Chemoreceptors will
only be activated by particular chemicals, and thermoreceptors will only be
stimulated by changes in temperature.
In mammals, most discriminative light touch sensation is mediated by the Aβ lowthreshold mechanoreceptors. Specialized Aβ low-threshold mechanosensory
receptor end organs are classified into several different subtypes based on their
structure. These include Meissner’s corpuscles, Pacinian corpuscles, lanceolate
endings and Ruffini corpuscles (Fleming & Luo, 2013).
Meissner’s corpuscles have an extremely low threshold for activation, responding to
an indentation of the skin of less than 10µm. Meissner’s corpuscles have relatively
small receptive fields and are most sensitive to low intensity stimuli (Fleming & Luo,
2013). They are therefore sensitive to light touch, and although they can be found all
over the skin, they are concentrated in sensitive regions such as the finger tips and
lips. Pacinian corpuscles sense vibration and the fine texture of objects, while the Aβ
low-threshold mechanoreceptors innervating hair follicles are lanceolate endings.
Ruffini corpuscles act as stretch receptors, and appear to work with other
proprioceptors to sense the position of the fingers and hands.
Thermosensation is another sensory modality of the skin. Besides contributing to the
temperature perception of an external stimulus it also contributes to the
identification of an object through touch, by providing information about the
10

temperature of that object. Thermosensation is an important mechanism which
contributes to the maintenance of a homeostatic condition in the body and it
provides a protective function by detecting noxious hot or cold stimuli. Cutaneous
thermosensation is mediated by a variety of primary afferent nerve fibres that
transduce, encode and transmit thermal information. Specialized thermoreceptors
are embedded in the free nerve endings of afferent fibres. Six “families” of
thermoreceptors, known as transient receptor potential (TRP) ion channels, have
been identified, whose activity depends on the temperature of the environment.
Each of these receptor types is only activated over a particular range of temperatures,
but together the receptors detect a full range of temperatures from noxious cold to
noxious heat. Some of the thermoreceptors are specific to temperature only, while
some of the thermoreceptors detect mechanical and chemical changes too, making
them polymodal receptors (Schepers & Ringkamp, 2009).
Nociceptors are sensory receptors that detect noxious stimuli. They can be highly
specialized responding only to injury and inflammation, but they can also be relatively
unspecialized, known as “polymodal”, responding to extreme and potentially
damaging mechanical, thermal and chemical stimuli. Despite each neural afferent
having specialized receptors, once all these receptors are activated, the process of
converting a specific stimulus into an electrical signal and conducting it along the
length of the nerve to the specific synapses at the dorsal horn, is identical (van
Griensven, 2005).
In a resting state, a voltage difference or “potential” exists across the membranes of
nerve axons, creating an overall positive external environment compared with the
negative interior. This is generated by active “ion pumps” in the membranes
separating the positive sodium and potassium ions from the negative chloride ions.
Ion channels in the cell membranes can be opened by mechanical force (in the case
of mechanoreceptors), by specific chemicals known as ligands (in the case of
chemoreceptors and thermoreceptors), or by direct depolarisation via an externally
applied electrical charge. When these ion gates open, there is a rush of negative
electrons through the gates as a result of the voltage across the membrane changing
11

the electrical charge of the nerve locally. Once this charge reaches its threshold, an
action potential is created which results in the adjacent ion gates opening and the
same cycle of depolarisation beginning there. This continues along the axon
membrane allowing an electrical impulse to be carried along the nerve to its synapse.
This process reflects the notion that impulses are generated in an ‘all-or-nothing’
fashion; the stimulus has to be sufficiently intense (noxious) to initially open the ion
channels which will then propagate its own electrical impulse. Once depolarised, the
membrane is restored to its normal resting state by the ion pumps. The stronger the
stimulus, the more frequently action potentials will be generated, a process referred
to as rate encoding. This entire process of converting a specific stimulus into an
electrical impulse is known as transduction, whilst the impulse travelling along the
nerve is referred to as transmission (van Griensven, 2005).
This transmission of information via electrical impulses from the peripheral tissues to
the central nervous system results in a conscious perception of events occurring in
the peripheral tissue. Two types of afferent fibres exist for transmitting nociceptive
signals; unmyelinated C fibres and myelinated A Delta fibres. Both are relatively thin
which means they conduct signals more slowly than other sensory afferents, but
because of the presence of the myelin sheath, the A Delta fibres convey the impulses
faster than the C fibres. This myelin sheath originates from the Schwann cells in the
peripheral nervous system and the oligodendroglial cells in the central nervous
system. The myelin insulates the axon, however it is not continuous along the entire
length of the axon. There are spaces between the cells, termed Nodes of Ranvier,
where the axon membrane is left exposed. These nodes are critical to the conduction
of the impulse along the axon because the membrane underlying the myelin cannot
undergo depolarisation and so this can only occur at the Nodes of Ranvier. The
impulse therefore hops along the axon from node to node and is termed saltatory
conduction. This conduction occurs at a much faster rate than the conduction of an
impulse along an unmyelinated membrane via depolarisation of each adjacent
segment of the membrane. Transmission along an A Delta fibre occurs at 4-36m/s,
while that along C fibres occurs between 0.4-3m/s (van Griensven, 2005).
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The receptors at the terminals of the afferents are specific to the fibre type.
Polymodal receptors, which are stimulated by chemical, thermal or mechanical
stimuli, are generally associated with C fibre types. Mechanical nociception tends to
be transmitted by A Delta fibres while thermal nociception is subserved by both A
Delta and C fibres. As a result of the different conduction speeds, receptor field sizes
and the speed of accommodation of these two fibre types, we are able to perceive
different qualities in the nature of one noxious stimulus. The A Delta fibres tend to
give rise to the perception of a short-lived, sharp pain while the C fibres generally
evoke a more diffuse aching or burning with longer-lasting effects. (van Griensven,
2005).
Once a nociceptive afferent has been sufficiently stimulated to trigger an action
potential, stored neuropeptides in the peripheral terminals of the neuron, such as
substance P and Calcitonin Gene Related Peptide (CGRP), are released into the local
tissues from whence the stimulus arose. This has the effect of causing vasodilation of
the local capillaries and stimulation of mast cells to release histamine. Together,
these effects result in an increased collection of interstitial fluid as the plasma leaks
from the permeable blood vessels. The histamine also has a sensitising effect on the
nerve endings in the area by lowering the membrane potential, facilitating
depolarisation and generation of action potentials. Besides the neuropeptide being
released when a nociceptor is activated, antidromic impulses are also generated.
Most of the impulses travel proximally along the fibre tract towards the spinal cord,
but antidromic impulses are those that stray from the general direction of the
current, to flow down branches of the same fibre tract toward other peripheral
terminals. When these impulses arrive at the terminals further neuropeptides are
released in this vicinity which will in turn have a vasodilatory effect and cause
increased amounts of histamine to be released from mast cells into this new area.
This in turn, increases local inflammation. The area may appear red and the increase
in blood flow to the area increases the local temperature. Swelling results from
oedema in the extravascular space and this can further induce pain due to the
stretching and distortion of the tissue.
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2.2.2 Spinal cord.
The dorsal horn of the spinal cord is the ultimate target and relay station for the
primary nociceptive afferents and the impulse conveyed by them. The dorsal horn is
comprised of six distinct layers according to the specific modalities that the afferent
neurons, which terminate there, convey. Despite the distinct laminae, there are
branched collateral connections between lamina layers which are likely to allow for
‘cross-talk’ between nociceptive and non-nociceptive afferents at this level. It is
thought these potential connections may play a role in pain modulation (Basbaum &
Jessel, 2000).
Second order neurons in lamina I (marginal layer) are primarily nociceptive specific
neurons that respond only to noxious and thermal stimuli, receiving input from
afferent A Delta and C fibres, which synapse directly with them in the dorsal horn.
These are known as nociceptive-specific neurones (NS neurones). Some of the
neurones respond to a variety of stimuli and are known as wide-dynamic range
neurones. Lamina V contains wide-dynamic range neurones which ascend to the
brain stem and the thalamus. A β and A Delta fibres synapse in lamina V, so the
neurons are activated by both noxious and non-noxious stimuli in this lamina. The
neurons in this lamina have dendrites which extend into lamina I and are activated
by the afferent C fibres which terminate in lamina I. It is within lamina V that the
visceral and somatic nociceptors converge which could potentially explain the
phenomenon of referred pain (Basbaum & Jessel, 2000).
Lamina II (substantia gelatinosa) is made up of tightly-packed interneurons activated
by noxious and non-noxious stimuli, having both an excitatory and an inhibitory
function. The majority of neurons in lamina II receive information from sensory dorsal
root ganglion cells as well as descending dorsolateral fasciculus (DLF) fibres. This
lamina is believed to be important for the modulation of sensory/nociceptive input.
Interneurones sensitive only to the Aβ neurones that synapse with them are
concentrated in lamina III and IV and VI. They carry predominantly non-noxious
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information and are arranged topographically according to the receptive fields of the
afferent neurones. Some of the dendrites of lamina IV project to lamina II and
possibly contribute to its modulatory function (Basbaum & Jessel, 2000). Lamina VII,
found in the ventral horn, is polysynaptic and responds to noxious and non-noxious
stimuli. It also receives input from both sides of the body, unlike the dorsal horn
laminae, which may explain the diffuse nature of some pain conditions.
Laminae I and V appear to be the laminae which play a direct role in the transmission
of nociceptive signals up the spinal cord, while the other laminae potentially
contribute to pain modulation, which occurs mainly in lamina II, via their cross-links
with that lamina. Glutamate and substance P are the excitatory neurotransmitters
released by the C and A Delta fibres in the dorsal horn to facilitate the transmission
(Basbaum & Jessel, 2000).
The nociceptors synapse with spinal interneurons and the ascending fibres of the
spinal cord in laminae I and V within the dorsal horn of the spinal cord. From here the
ascending nociceptive signals are transmitted up the spinal cord to higher centres for
processing through five tracts.
The spinothalamic tract relays impulses to the thalamus. The axons cross the midline
then ascend in the anterolateral white matter to the thalamus. The medial and lateral
nuclei of the thalamus are primarily involved in nociception. Fibre tracts that project
to the lateral nuclear group and the nuclear neurons, have small receptor fields and
appear to play a role in the localisation of pain. The medial nuclei assist in processing
nociceptive information and have projections which extend into the various cortical
areas, such as the insular cortex, cingulate gyrus and the basal ganglia. The cingulate
gyrus is part of the limbic system and is thought to be involved in the processing of
the emotional component of a pain experience. The insular cortex contributes to the
internal body response to the pain experience via the autonomic nervous system
(Basbaum & Jessel, 2000).
The spinoreticular tract relays information in the anterolateral white matter of the
spinal cord to both the thalamus and the reticular formation, a neural network in the
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brainstem which regulates the cardiovascular system, respiratory system and the
sleep-wake cycle. The reticular formation is also responsible for posture, balance and
motor function. In contrast to the spinothalamic tracts, these axons do not cross the
midline. The spinomesencephalic tract axons run in the anterolateral quadrant and
the dorsal part of the lateral funiculus, and is thought to contribute to the affective
component of pain via its projections to the amygdala via the mesencephalic reticular
formation and periaqueductal grey matter. The cervicothalamic tract fibres arise
from the lateral white matter of the upper two cervical segments. They terminate in
the cuneate and gracile nuclei of the medulla. These nuclei participate in the
sensation of fine touch and proprioception. Finally, the spinohypothalamic tract
projects to supraspinal autonomic control centres which regulate neuroendocrine
and cardiovascular responses (Basbaum & Jessel, 2000).

2.2.3 Brain structures involved in pain perception.
Recent developments in structural and functional imaging methods have
revolutionised neuroscience providing researchers with a better understanding of
the organisation and behaviour of the brain. Structural imaging examines anatomical
structure while functional imaging reveals physiological activity within particular
tissues using tracers to reflect their spatial distribution within the body.
Hemodynamic imaging methods rely on the fact that cerebral blood flow and
neuronal activation are coupled. When an area of the brain is in use, blood flow to
that region also increases. This method of imaging has allowed us to establish which
areas of the brain are involved in pain perception. Electroencephalography (EEG) and
magnetoencephalography (MEG) are other forms of functional imaging which are
useful for demonstrating temporal sequencing and time delays in brain activation
(Apkarian, Bushnell, Treede, & Zubieta, 2005). EEG is a monitoring method to record
electrical activity in the brain, while MEG is a technique used to map brain activity by
recording magnetic fields produced by electrical currents occurring with brain
activity.
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According to Basbaum and Jessel (2000) there are regions in the cerebral cortex
which respond exclusively to nociceptive input. These authors believed these to be
found in the somatosensory cortex, the cingulate gyrus and insular cortex. However
a review by Legrain, Iannetti, Plaghki, and Mouraux (2011) disputed this and
proposed that the areas that were once thought of as nociceptive specific are better
thought of as salient specific. Nociception is just one of many types of salient
information that gives rise to a particular salient specific neurosignature. Eventrelated brain potentials (ERPs) elicited in response to a salient stimulus involve three
processes, namely the detection, localisation and reaction to a salient and potentially
dangerous physical threat. These processes involve a wide range of sensory
integration, such as visual and proprioceptive perception, not solely the processing
of nociceptive input so the ERPs noted reflect this multisensory integration. Various
brain centres have displayed ERPs in response to a salient noxious stimulus, hence
contributing to the processing of nociceptive input and the ultimate perceived pain
experience (Legrain et al., 2011).
The primary somatosensory cortex (S1), secondary somatosensory cortex (S2) and
the posterior portion of the insular cortex (IC) are commonly and concurrently
activated following noxious stimulation, unlike that observed with tactile stimulation,
where the IC and S2 are activated only after processing of the stimulus in S1. The S2
and IC are therefore primary receiving regions for nociceptive input to the brain.
These regions are thought to contribute to the sensory-discriminative functions of
pain. The organisation within the S1 appears to follow the same somatotopy as
observed for tactile input, however the evidence of this existing in S2 as well has not
yet been established (Apkarian et al., 2005).
As presented in the systematic review by Apkarian et al. (2005) one study
demonstrated that visceral and cutaneous noxious input both led to activations in S1,
S2, anterior cingulate cortex (ACC) and IC, but the exact area within the regions
differed for the two types of pain. This suggests that there are potentially sub-regions
within the brain structures responsible for processing noxious stimuli from different
types of tissue.
17

The prefrontal cortex (PFC), is a heterogeneous brain area with the various gyri
contributing to cognitive, emotional and memory function. The PFC, as well as
parietal association areas, are involved in the cognitive components of pain
perception such as memory or stimulus evaluation (Apkarian et al., 2005).
While the posterior IC is involved in the sensory nature of pain perception, the
anterior IC is part of the limbic system and is more closely linked anatomically and
functionally to the PFC. and hence appears to contribute to the emotional, cognitive
and memory related aspects of pain perception (Apkarian et al., 2005). The cingulate
cortex, particularly the ACC is also a component of the limbic system, however it acts
as an important interface between emotion and cognition, and is therefore involved
in the cognitive-evaluative stages of pain processing. It is thought to be responsible
for the affective-motivational component of pain (Apkarian et al., 2005).
Subcortical activations, particularly in the thalamus, basal ganglia, and cerebellum,
have also been observed during noxious stimulation, as well as activity in the motor
and pre-motor cortical areas. It is thought that the motor and pre-motor cortices may
be involved in pain-evoked movements, altered motor patterns or suppression of
movement in the presence of perceived pain (Apkarian et al., 2005).
Significant differences appear to exist between the parts of the brain involved in
processing acute/experimental pain in normal subjects compared to the activation
patterns seen in persistent clinical pain. Greater activation of the spinothalamic
pathway, which transmits afferent nociceptive information through the thalamus to
S1, S2, IC and ACC is observed with experimental pain induced in normal subjects,
whereas with experimental pain induced in chronic clinical pain populations the
proportion of activity in these primary sensory-evaluative areas is comparatively less,
while the activation in the PFC is increased. As a result, it is postulated that the
nociception transmission through the spinoparabrachial, spinohypothalamic and
spinoreticular tracts is likely to increase. The emphasis shifting towards augmented
PFC activity in the chronic pain conditions suggests a greater component of emotional
and cognitive processing associated with the chronic pain state, and reduced sensory
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processing. Thalamus activity is seen to increase temporarily as pain persists, but over
time the activity actually diminishes. Decreased stimulus-related activity has been
observed in this structure in chronic pain sufferers (Apkarian et al., 2005). A study
using various brain imaging techniques confirmed a reduction in the anatomical size
and function of the thalamus associated with chronic pain conditions, in particular,
trigeminal neuralgia. This was proposed to impact on the thalamocortical circuitry
resulting in persistent pain (Henderson et al., 2013).
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2.3

Modulation of Pain

Under normal circumstances it is generally assumed that our perception of pain is
coupled with the amount of noxious information being received from peripheral
tissue. However, pain is a complex phenomenon. Nociceptive input is modulated by
various factors at various levels which can allow for the production of a very different
pain experience which is not reflective of what is actually occurring at the tissue level,
in fact nociception is neither sufficient nor necessary to produce the experience of
pain (Butler & Moseley, 2013). Modulation appears to occur in the periphery at the
nociceptor terminals, within the dorsal horn of the spinal cord, and in supraspinal
centres.

2.3.1 Peripheral modulation of pain.
Peripheral nociceptors may be sensitised and even activated by certain stored
chemicals released from the terminals and local tissue cells. This is known as
peripheral sensitisation. Some of the substances that lower the threshold of
nociceptors include histamine, which is released by damaged mast cells, and
bradykinin, a chemical also released by damaged cells. These lower the threshold and
bring about more regular depolarisation, and once this occurs nociceptors release
stored neuropeptides, such as substance P which act directly on the local capillaries
causing vasodilation, resulting in oedema. This process is termed neurogenic
inflammation as it is induced by nociceptor stimulation. Substance P is an excitatory
neurotransmitter thought to be related to the transmission of pain information into
the central nervous system at the dorsal horn. Substance P also sensitises the
receptors in the periphery by causing undamaged mast cells to release more
histamine. Reverse-flowing antidromic neural impulses also serve to further sensitise
the local nociceptors and even those adjacent to injured areas, by resulting in the
release of neuropeptides (Basbaum & Jessel, 2000).
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The reduction in the threshold of these peripheral nociceptors underlies primary
hyperalgesia, an increased pain experience to a noxious stimulus as a result of the
increased sensitivity in the peripheral nociceptors (Woolf & Decosterd, 1999).

2.3.2 Modulation of pain in the spinal cord.
2.3.2i The dorsal horn.
Modulation of pain also appears to occur within the spinal cord at the level of the
dorsal horn. Inhibition of nociception occurs through the Gate Control mechanism,
while facilitation of nociception occurs through the process of central sensitisation
(Basbaum & Jessel, 2000). Furthermore, the descending pain modulatory system
appears to be able to modulate pain in the dorsal horn in both an inhibitory or
facilitatory direction as a result of activity in pain-related brain regions, linked to the
dorsal horn by a network of neurons (Zusman, 2002).

Central Sensitisation

In response to nociceptor input dorsal horn neurons exhibit changes which can
profoundly alter sensitivity by increasing membrane excitability, facilitating synaptic
strength and even decreasing inhibitory influences in dorsal horn neurons
(Latremoliere & Woolf, 2009). This state of temporary hyperexcitability can progress
to a lasting state in the dorsal horn neurons. Together these processes are known as
central sensitisation (Basbaum & Jessel, 2000). Central sensitisation comprises two
distinct phases.

The earlier stage of central sensitisation

The first phase is the early phosphorylation-dependent and transcriptionindependent phase. To induce central sensitization, C fibres terminals in somatic or
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visceral tissue must undergo intense, repeated or sustained noxious stimulation
(Latremoliere & Woolf, 2009). This results in rapid changes in glutamate receptor and
ion channel properties (Latremoliere & Woolf, 2009). A fast augmentation of
excitatory glutamatergic synapses in the superficial dorsal horn strengthens
nociceptive transmission and recruits non-nociceptive input to the pathway. This is
achieved by phosphorylation of numerous receptor and ion channel targets that lead
to changes in threshold and an increase in the release of glutamate, substance P and
CGRP. (Latremoliere & Woolf, 2009).This process is known as windup. It is perceived
as an increase in pain intensity over time while a noxious stimulus is applied. Windup
disappears within tens of seconds of the end of the stimulus train as the membrane
potential returns to its normal resting level (Latremoliere & Woolf, 2009).
Once phosphorylated in the process described above, protein kinase-C (PKC)
decreases inhibitory transmission at the segmental level by reducing gamma aminobutyric acid (GABA) inhibition and the descending inhibition driven from the
periaqueductal grey matter (PAG). Disinhibition leaves dorsal horn neurons more
susceptible to activation by excitatory inputs including non-nociceptive A-fibres.
Elevation in intracellular calcium is also a major trigger of central sensitisation,
activating multiple calcium-dependent kinases that act on receptors and ion channels
to increase synaptic efficacy. Sustained release of glutamate by peripheral
nociceptive activity and the neuropeptides substance P and CGRP leads to sufficient
membrane depolarization to force magnesium ions (Mg2+) to leave the N-methyl-Daspartate receptor (NMDAR) pores, whereupon glutamate binding to the receptor
generates an inward current of calcium ions (Ca2+) into the neuron. The increase in
Ca2 concentration then activates numerous intracellular pathways, such as the
extracellular signal-related kinase (ERK) that can contribute to the maintenance of
central sensitization. Once activated, the ERK cascade results in changes in the
threshold and activation kinetics of NMDA and α-amino-3-hydroxy-5-methyl-4isoxazolepropionic acid (AMPA) receptors, boosting synaptic efficacy. A key feature
of acute activity-dependent central sensitization is that it typically lasts for tens of
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minutes to several hours in the absence of further nociceptor input (Latremoliere &
Woolf, 2009).
A peripheral stimulus is required initially to trigger central sensitisation, but once
sensitized, noxious, non-noxious (e.g. A β stimulation) or even no stimulus can initiate
an impulse in second order dorsal horn neurons. This is termed stimulus-generated
pain hypersensitivity. The second-order neurones have a large number of
“subliminal” connections with surrounding areas. Prior to sensitization a normal
somatotopic map and sensory specificity is maintained, however following
sensitization these connections start to respond more readily (Zusman, 2002).
Clinically, this may present as hyperalgesia (known as secondary- or centrallymediated hyperalgesia), tactile allodynia, temporal summation, referred pain,
hypersensitivity to thermal stimuli and even spontaneous pain at the stimulated site,
but also at adjacent areas and even spreading to normal, more distant tissues
(Basbaum & Jessel, 2000). Central sensitisation may also result in an increased
duration of the painful experience, longer than would be expected from a particular
stimulus.
This increase in sensitivity noted in the early stage of central sensitization is
protective, because it helps healing by limiting use of an injured body part until the
injury is fully repaired (Latremoliere & Woolf, 2009). The hypersensitivity state is
usually fully reversible, returning ultimately to its normal resting state, termed “basal
sensitivity” (Woolf, 2011). It becomes pathological when central sensitization is
maintained in the absence of active peripheral pathology (Latremoliere & Woolf,
2009).

The later stages of central sensitisation

In cases of sustained noxious input or sustained high perceived threat, central
sensitisation may persist. Different transcription-dependent changes are required for
longer-lasting effects, and these generally do not occur in response only to brief
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nociceptor activity but are the consequence of sustained input due to peripheral
inflammation and nerve injury (Latremoliere & Woolf, 2009), though sustained
descending excitatory input from higher centre may produce the same outcome (Bee
& Dickenson, 2008). This later transcription-dependent phase drives synthesis of the
new proteins responsible for the longer-lasting form of central sensitization observed
in several pathological conditions. For example, ERK can lead to the activation of the
transcription factor cAMP response element-binding protein (CREB) which drives
expression of genes producing a long-lasting strengthening of the synapse
(Latremoliere & Woolf, 2009). Also, as a result of peripheral inflammation the
expression of centrally-acting neurotransmitters is increased, lowering the threshold
allowing for more frequent or easily activated dorsal horn neuron depolarisation
(Basbaum & Jessel, 2000).
Central sensitization represents not only a state in which pain can be triggered by less
intense inputs but in which the central sensitization itself can be maintained by a
lower level or different kind of input. Ongoing activity in C-fibres, even at levels that
do not initiate central sensitization in normal conditions, is sufficient to maintain
central sensitization once it has been induced for prolonged periods (Latremoliere &
Woolf, 2009).

Gate Control

This nociceptive-inhibitory phenomenon involves the activation the A β fibres. Nonnociceptive A β (for perception of sensation) and nociceptive A Delta and C fibres
converge onto common neurons in laminae I and V of the dorsal horn. Interneurons
found in laminae I and II of the dorsal horn release inhibitory neurotransmitters, such
as GABA, encephalin or dynorphin (endogenous opioid neurotransmitters). When
activated, these neurotransmitters bind to μ-opioid receptors on the axons of
incoming C and A-delta fibres carrying pain signals from nociceptors activated in the
periphery. The activation of the μ-opioid receptor inhibits the release of substance P
from these incoming first-order neurons and, in turn, inhibits the activation of the
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second-order neuron that is responsible for transmitting the pain signal up the
spinothalamic tract to the ventroposteriolateral nucleus (VPL) of the thalamus
(Pertovaara & Almeida, 2006). Thus, by selectively stimulating the A β fibres it
appears we can reduce the input from the nociceptive A Delta and C fibres in these
laminae. The use of transcutaneous electrical nerve stimulation (TENS) is based, in
part, on the Gate Control Theory. It is important to note that an analgesic effect is
only created if the A β stimulation is in an anatomically similar region to the area of
the nociceptor stimulation, as the respective afferents are required to converge at
the same level in the dorsal horn in order to establish this “gating control” of pain
(Basbaum & Jessel, 2000). The A β fibres are not directly activated by noxious stimuli,
however they appear to contribute to the perception of the quality of the noxious
stimulus. Therefore, in summary, activation of A β fibres contributes to perception of
stimulus quality but also appears to attenuate it.

2.3.2ii The descending pain modulatory system
A network of neurons exists in the spinal cord linking the pain-related brain regions
to the dorsal horn. This network modulates nociception at the dorsal horn, as a result
of brain activity in these areas. Activation of the neurons can induce both an
excitatory and inhibitory effect on nociception, with the overall effect being the net
result of the facilitatory and inhibitory influences. Under normal circumstances this
appears to be inhibitory however this balance can be easily influenced by various
factors (Zusman, 2002)

Nuclei involved in descending pain modulatory system

The PAG, located in the mesencephalon around the Sylvius aqueduct, exerts a
powerful pain modulatory action. Afferent fibres from the spinothalamic tract
synapse at the PAG. Neural traffic from the PAG is connected to the spinal cord via
the rostral ventromedial medulla (RVM). The RVM is a group of neurons located close
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to the midline on the floor of the medulla oblongata. The RVM includes the nucleus
raphe magnus (NRM) and adjacent reticular formation, including the nucleus
gigantocellularis pars and paragigantocellularis ventralis, all of which project directly
to the spinal cord. The PAG sends efferent connections to the nucleus raphe magnus
when it is stimulated by opiates (Pertovaara & Almeida, 2006). Both the PAG and
RVM receive direct afferent projections from the spinal dorsal horn and, thus, they
may control the ascending nociceptive input by a simple feedback mechanism.
The rostral ventromedial medulla (RVM) sends descending inhibitory and excitatory
fibres to laminae I, II and V of the dorsal horn spinal neurons. Three categories of
neurons have been identified in the RVM: “Off-cells” which are inhibitory; “on-cells”
which are facilitatory/nociceptive; and neutral cells which show no response to
nociceptive input (Pertovaara & Almeida, 2006). That the spinal cord pain pathway
neurons can assert a nociceptive and antinociceptive influence indicates the
bidirectional nature of the brainstem descending modulatory system.
The NRM receives descending afferents from the periaqueductal grey, the
paraventricular hypothalamic nucleus, central nucleus of the amygdala, lateral
hypothalamic area, parvocellular reticular nucleus and the prelimbic, infralimbic,
medial and lateral precentral cortices. All of these brain areas influence the main
function of the nucleus raphe magnus, that is, pain modulation. Projections extend
to the dorsal horn of the spinal cord to directly inhibit nociception. When stimulated,
the nucleus raphe magnus releases serotonin, a neurotransmitter which suppresses
nociceptive input.

Inhibition

The descending inhibitory systems can impose an inhibitory effect on the ascending
nociceptive signals but they can also serve to “focus” the painful signal by suppressing
the surrounding extraneous neuronal activity, thereby reducing the level of “noise”
in the nervous system (Zusman, 2002). Diffuse noxious inhibitory control neurons are
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located in the caudal medulla (Lewis, Kersten, McCabe, McPherson, & Blake, 2007).
Activation of these neurones is the mechanism by which the diffuse noxious
inhibitory control system (DNIC) produces a top-down inhibitory effect on a painful
stimulus. Descending inhibitory systems will serve to mask the “noise” of underlying
pain when a “new” painful stimulus is applied in order to help focus the new painful
stimulus (Zusman, 2002). Although DNIC involves a descending inhibitory influence,
it has been postulated that the net effect of DNIC is clarification of pain perception
evoked by the most threatening noxious stimulus (Pertovaara & Almeida, 2006).
Clinical studies indicate that in patients with fibromyalgia a reduction of DNIC
potentially contributes to hyperalgesia (Pertovaara & Almeida, 2006).
The descending inhibitory tracts and nuclei may be activated by various mechanisms.
Descending pain inhibitory pathways have an important role in the ascending–
descending circuitry, providing negative feedback control of nociceptive signals at the
spinal cord level. Therefore, full activation of descending inhibition is observed only
under painful conditions (Pertovaara & Almeida, 2006). Higher brain centres
associated with cognition, motion, mood and behaviour recruit descending pain
modulatory pathways. Some centrally-acting analgesic drugs are effective by
inducing activation of descending pain inhibitory pathways (Pertovaara & Almeida,
2006).
The dorsolateral funiculus appears to be the main pathway for descending pain
inhibitory systems between the RVM and dorsal horn (Zusman, 2002). There are
several ways in which the descending inhibitory tracts suppress nociceptive signals:
1. Neurotransmitters released from descending axons may block the ascending
nociceptive signal by producing a hyperpolarization of spinal relay neurons
(Pertovaara & Almeida, 2006).
2. Descending pathways may also suppress nociceptive signals due to action on
central terminals of primary afferent fibres (presynaptic inhibition). These
terminals have receptors specific to the inhibitory neurotransmitters released in
the descending spinal cord (Pertovaara & Almeida, 2006).
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3. Gate Control theory of pain. The axons of the neurons within the dorsolateral
funiculus terminate on inhibitory interneurons in the dorsal horn of the spinal
cord. These interneurons, in addition to being subject to the segmental influence
of peripheral origin in the Gate Control mechanism, may therefore also be subject
to an activation of central origin. The interneurons in the dorsal horn exert their
inhibitory effect by releasing endogenous opioids that act on specific receptors
located both in the terminals of the primary nociceptive afferents and directly on
the converging neurons, that is, pre-and post-synaptic inhibition.
Activation of projections from the PAG to the brainstem nuclei (RVM and locus
coruleus) and then to the dorsal horn of the spinal cord, involve neurotransmitters
such as opioids, noradrenalin, and serotonin which have modulatory (both excitatory
and inhibitory) influences on spinal cord afferent neurons. Opioids are strong
analgesics which work at various sites within these descending tracts, preventing the
passage of nociceptive signals through the dorsal horn and into higher levels of the
brain where the perception of pain is generated (Basbaum & Jessel, 2000).

Facilitation

The nucleus reticularis gigantocellularis (NGC) in the medulla appears to be the origin
of the descending facilitatory system. Activation in the NGC also appears to suppress
the function of the inhibitory “off cells” in the RVM via inhibitory interneurons. A
pathway exists between the dorsal reticular nucleus of the medulla and the dorsal
horn of the spinal cord, which amplifies afferent nociceptive input and possibly
contributes to central sensitization (Zusman, 2002).

2.3.3 Supraspinal modulation of pain.
There is evidence from functional magnetic resonance imaging (fMRI) studies
showing that processing of nociception involves the activation of a diffuse network
of transmitting fibre tracts and brain centres that are not exclusively devoted to pain
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(Jabbur & Saadé, 1999). These centres receive afferent nociceptive input via multiple
routes (Bushnell, Čeko, & Low, 2013). Prior to the production of the final pain
experience the ascending afferent nociceptive signals are modulated supraspinally.
A large number of brainstem, diencephalic (thalamic and hypothalamic) and
telencephalic (cortical and sub-cortical) structures modulate pain through
descending projections to the spinal dorsal horn, and in most cases their descending
pain modulation effect is relayed through the PAG and the RVM (Pertovaara &
Almeida, 2006).
There is substantial evidence for pathways from these “pain-involved” cortical and
subcortical regions to both the PAG and RVM to facilitate this supraspinal modulation
(Zusman, 2002) and input from these centres most likely influences the balance of
inhibitory versus facilitatory effects of the descending modulatory tracts. The RVM
and PAG in the brainstem and the descending modulatory pain tracts play a pivotal
top-down role in modulating the afferent nociceptive input prior to higher-order
processing. These mechanisms of pain modulation influence the ultimate pain
experience (Tracey & Mantyh, 2007).
Connections between forebrain structures and the nuclei within the brainstem,
particularly the RVM and PAG, have been identified. These include the ACC, IC and
certain subcortical amygdala and hypothalamic nuclei (Zusman, 2002). Connections
from higher centres of processing such as the S1, S2, posterior parietal, and insular
cortices converge on the ACC together with connections from the prefrontal cortex
(which is concerned with planning a response to the painful stimulus). The ACC,
therefore, plays a major role in the integration of the sensory, affective, attentional,
cognitive and emotional components of pain. Through its direct and indirect
connections with the RVM and PAG, the ACC influences the descending modulatory
system in a bi-directional manner and helps to explain how cognitions, beliefs,
emotions, context and attention can influence our perception of pain (Zusman,
2002). Particular personality traits, emotional states and cognitive styles lend
themselves to the amplification and persistence of perceived pain via these
connections from cortical /subcortical brain regions to the brainstem (Zusman, 2002).
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2.4

Interaction between Pain and Emotional Factors

Various pain-related pathways in the brain are responsible for different aspects of
the pain experience. With recent advances in imaging we have been able to recognise
various parts of the brain associated with the processing of the emotional component
of a pain experience, and the various parts of the brain which appear to be activated
by emotional states and exhibit a top-down modulatory effect on the afferent
information. The ACC and the insula are part of the limbic system of the brain which
is primarily involved in a person’s emotional state. These regions are important for
encoding the emotional components of pain (pain affect). They are linked directly to
the PAG, and are commonly termed the “medial system” (Tracey & Mantyh, 2007).
The amygdalae are almond-shaped nuclei in the temporal lobe of the brain, and are
also part of the limbic system. They play an important role in emotional behaviour.
Nociceptive afferent inputs through the spino–parabrachio–amygdala pathway
probably contribute to pain-induced changes in affective behaviour. Likewise, the
connections from the amygdala to the PAG and RVM may be involved in mediating
the influence of emotions on pain. Stressful situations like physical exercise, exposure
to extreme temperatures, fight, fear and pain may induce a decrease in pain
sensitivity, a phenomenon called stress-induced analgesia. The hypothalamus is likely
involved in stress-induced analgesia (Pertovaara & Almeida, 2006).
The emotional component of the pain experience is powerful. Studies have shown
that a noxious stimulus is not actually required to activate pain pathways and even
to perceive pain, if a subject is adequately emotionally “primed”. This occurred in
subjects while they were merely observing other individuals in pain (Lamm, Decety,
& Singer, 2011). Also, when “emotionally primed” the subject’s perceived pain levels
to a noxious stimulus was reported to be higher than without the priming (Loggia,
Mogil, & Bushnell, 2008).
It is difficult to induce a psychological state of anxiety/depression in the experimental
environment and hence experiments are limited to inducing sadness or a depressed
mood in subjects. In a study by Berna et al. (2010) subjects underwent a “sad” mood
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induction process by means of reading “Velten-type” statements (commonly used to
induce moods in psychological experiments) along with sad background music. They
were deemed to have experienced a sad mood induction if they achieved a greater
than 40% increase in their depressed mood score. The subjects were exposed to a
noxious thermal stimulus and the brain activation patterns compared to those
observed when the subjects were exposed to the same stimulus in a “neutral mood”.
The results indicated that the induction of depressed mood augments the ratings of
pain unpleasantness. The major difference noted using fMRI was the increased
activity in the greater inferior frontal gyrus and amygdala in those subjects who
reported the largest increase in pain unpleasantness. This demonstrates a potential
link between changes in emotion control mechanisms and enhancement of pain. The
researchers suggest that this may explain how depressed mood and chronic pain may
co-occur (Berna et al., 2010).
Anxiety and depression are together referred to as “emotional distress” as it is often
difficult to separate the two states diagnostically, particularly in children. The
psychological states of anxiety and depression have been clinically demonstrated to
augment the pain experience. It appears this is likely to be due to the increased
attention focussed on the pain. For example, one study showed that subjects who
were predisposed to anxiety and who were fearful of dental intervention both
expected and experienced more pain than non-anxious subjects during restorative
dental procedures (Klages, Kianifard, Ulusoy, & Wehrbein, 2006). Depressive
disorders often accompany persistent pain (Tracey & Mantyh, 2007) and currently it
is unclear which condition precedes the other. In an fMRI study of patients with
fibromyalgia activation in amygdala and anterior insula differentiated patients with
and without major depression, however the exact connections between pain and
depression have not yet been determined (Giesecke et al., 2005).
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2.5

Interaction between Pain and Cognitive Factors

The interaction between pain and cognitive factors has similarly undergone
significant investigation. Studies have revealed that cognitive processes can influence
pain behaviours and disability levels (Moseley, 2007). Cognitive processes appear to
activate the superior parietal lobe, the insula and the S1 somatosensory cortex which
is consistent with the role of these regions in pain sensation, rather than in pain
affect. They are collectively termed the “lateral system” (Bushnell et al., 2013). These
centres are linked to the ACC, PAG and RVM and thereby contribute to modulation
of pain-evoked activity via the descending modulatory system (Zusman, 2002).
Attentional focus seems to have a significant effect on acute pain perception.
Through their experiments, Miron, Duncan, and Bushnell (1989) demonstrated that
changes in the direction of attention alter the ability to discriminate noxious heat
stimuli. They further provided evidence that both the speed and accuracy of
detecting changes and the intensity and unpleasantness in noxious heat stimuli are
decreased when the subject attends to another stimulus modality. Focus towards the
nociceptive stimulus increases the pain experience while distraction decreases pain
(Miron et al., 1989). Moseley (2007) reported contrasting effects of attention. The
modulatory effect that attention has on pain perception seems to depend on the
underlying threat value of the pain to that individual, and the measure of control the
individual has over that pain. Nevertheless, despite the differences in direction of
effect, there appears to be a strong modulatory effect of attention on the pain
experience (Moseley, 2007).
Pain distracts our attention from current activity. The amount it interrupts our
attention is dependent on the intensity of pain or the perceived threat value. This
turns our concentration towards the pain, which may result in a psychological state
of hypervigilance (Vlaeyen, Crombez, & Goubert, 2007). In ongoing clinical pain states
hypervigilance, which is characterised by excessive attention towards sensory
information, augments our perception of pain (Vlaeyen et al., 2007) and has been
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shown to explain some of the variance in pain severity and serve as a potential barrier
to resolution in persistent pain problems.
Attribution, anticipation and anxiety are cognitive factors that reflect aspects of a
subject’s sense of control over a painful experience. In general, people with pain
often seek to attribute their symptoms to a specific cause or diagnosis. As pain
becomes more persistent, there is often no clear, physiological explanation for their
symptoms. This leads to a sense of loss of control which has been demonstrated to
augment the pain experience. In a study investigating the effect of a depressiveattribution style in healthy male subjects, causal attributions for negative events
were measured using the attribution style questionnaire (ASQ). A moderate
correlation was demonstrated between the perceived pain intensity (PPI) of the
electrical skin stimulus and the ASQ. Following uncontrollable stress exposure, the
PPI increased significantly and there was a higher correlation between PPI and the
ASQ (Müller, 2013). Anticipation and anxiety (as a trait) have also been shown to
modulate the pain experience. Anticipating pain is adaptive and important to prevent
potential injury. In an fMRI study, brainstem responses during anticipation and
processing of thermal noxious stimuli were investigated. The intensity of perceived
pain was shown to increase as the anticipation/ anxiety prior to the noxious stimulus
heightened (Fairhurst, Wiech, Dunckley, & Tracey, 2007).
Pain catastrophisation has been defined as a maladaptive “exaggerated negative
mental set brought to bear during actual or anticipated painful experience”, and is
thought to encompass the factors of helplessness, magnification and rumination
(Sullivan et al., 2001). Others have emphasised that catastrophising about pain also
encompasses “worrying about a major negative consequence from a situation, even
one of minor importance” (Turner, Jensen, & Romano, 2000). Catastrophisation
contributes to the pain experience and is associated with higher pain rating in both
experimental and clinical studies. Individuals registering high scores on the pain
catastrophisation scale report more intense pain (Sullivan et al., 2001), more severe
depression and anxiety (Keefe, Brown, Wallston, & Caldwell, 1989), show higher
levels of pain behaviour and disability (Sullivan, Lynch, & Clark, 2005) and have been
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shown to predict higher perceived post-operative pain levels (Pavlin, Sullivan, Freund,
& Roesen, 2005). It has been proposed that attention to pain underlies
catastrophisation. This has been substantiated by neuroimaging data revealing
increased activation in the cortical regions implicated in attention, vigilance and
awareness.
Expectation is the state of looking forward or anticipating a future occurrence. It is
the degree of probability that something will occur. Recently, the placebo modulatory
effect on pain was investigated as a form of inducing expectation (of relief) using a
molecular imaging approach. The researchers confirmed that placebo analgesic
effects are mediated by endogenous opioid activity on μ-opioid receptors. These
observations were extended to confirm that prefrontal mechanisms can trigger the
opioid release within the brainstem during expectancy to influence the descending
pain modulatory system and subsequently modulate pain perception (Wagner et al.,
2007).
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2.6

Multisensory Integration

Besides the influence of cognition and emotion on our perception of pain, the
intensity of pain may be influenced by the interaction from other sensory modalities,
such as tactile, nociceptive, auditory, olfactory, gustatory, and visual input. This
phenomenon is known as multisensory modulation (Haggard, Iannetti, & Longo,
2013). There has been significant interest in exploring the influence of multisensory
integration on the experience of pain.

2.6.1 Modulatory effects of tactile activity on pain perception.

The Gate Control mechanism of pain modulation discussed above, is a well-known
example of multisensory modulation, whereby interactions between touch and
nociceptive afferent stimuli at various levels, including the spinal cord, thalamus and
cortex, reduce the intensity of pain perceived (Melzack, 1996).

2.6.2 Modulatory effects of nociceptive activity on pain perception.

The DNIC system is another example of multisensory modulation of pain, this time
with acute nociception as the sensory input having a modulatory effect on underlying
pain.

2.6.3 Modulatory effects of auditory activity on pain perception.

The effects of different auditory input on pain tolerance and pain intensity have been
investigated by various groups. Music in different forms has been the most commonly
described auditory input.
Mitchell, MacDonald, and Brodie (2006) used experimentally induced cold pressor
pain to compare the effects of subject-preferred music to two types of distracting
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stimuli; mental arithmetic (a cognitive distraction) and humour (which may
emotionally engage us in a similar manner to music). Preferred music listening was
found to significantly increase pain tolerance time in comparison to the cognitive task
and in comparison to humour. Ratings of pain intensity on a visual analogue scale and
the pain rating index were not significantly different between the three distractions.
So the investigators concluded that preferred music distracts attention from
experimental pain significantly more than an affectively-neutral arithmetic task to
allow for an increased tolerance time but not significantly more effectively than
humour. The music used in this study was self-chosen and familiar, and therefore,
individual preferences and familiarity could enhance the drive to listen attentively to
the music and thus act as a distractor from the pain. The results also showed that
preferred music provides a significantly greater feeling of control over a painful
experience than a humorous distraction (Mitchell et al., 2006). These results were
corroborated by work from the same group showing that familiar music increases
pain tolerance more than unfamiliar music (Mitchell et al., 2006).
Roy, Peretz, and Rainville (2008) developed a hypothesis that the mechanism
underlying this established music-induced analgesia is mediated by the valence of the
emotions induced by the music. Positive valence refers to the intrinsic attractiveness
of the music while negative valence refers to the averseness. The results of this
experiment varied from the above-mentioned in that the researchers found that the
intensity of pain was affected, rather than just the subject’s pain tolerance. In their
study, only the pleasant excerpts of music significantly reduced pain intensity and
unpleasantness of a thermal stimulus, compared with unpleasant music and the
silent control condition. Pain reduction was negatively correlated to the subjects’
reports of pleasantness of music. These results supported their proposal that
pleasant music reduces pain more than unpleasant music (Roy et al., 2008).
Subsequently, in a study involving a clinical population of fibromyalgia patients, pain
ratings and timed-up-and-go tests were assessed while the subjects listened to selfchosen, relaxing, pleasant music versus a control group who listened to an even/flat
noise (termed “pink noise”). The experimental group demonstrated a significant
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reduction in pain ratings and improved functional mobility compared with the results
from the control group. The investigators went on to explain that the improved
functional mobility was not related to an improved motor rhythm derived from a
faster rhythm in the music because the effects were noted even if the music was
played before the mobility assessment rather than during the test (Garza-Villarreal
et al., 2014).
Villarreal, Brattico, Vase, Ostergaard, and Vuust (2012) extended the above findings
and demonstrated that valence of music alone is not an effective pain modulator. In
their study an active distraction of a cognitive arithmetic task reduced pain more than
the passive distractions with low arousal such as unfamiliar but pleasant music and
unfamiliar but pleasant environmental sounds. Arousal refers to the physiological or
psychological state of being awake or reactive to a stimulus. Although less effective
than the cognitive task, the environmental sounds and music still had an analgesic
effect and they reduced pain similarly to each other. Pain intensity was significantly
correlated with valence and arousal (Villarreal et al., 2012). Therefore, valence and
arousal are two interrelated emotional mechanisms that appear to be clearly linked
to the analgesic effect of music.
Pud and Sapir (2006) explored the influences of auditory stimulation and cognitive
tasks on intensity of pain perception of normal subjects to a heat stimulus. A nonmusic auditory stimulus in the form of a sinusoidally modulated speech-like signal
was used. In this experiment, there was a significant difference in the visual analogue
scale (VAS) ratings of the heat stimulus when the heat stimulus was applied in
isolation, as opposed to being applied in conjunction with the auditory stimulus or
with the auditory stimulus plus the cognitive task. The VAS rating dropped when
there was competing sensory input/processing, demonstrating a significant influence
of auditory +/- cognitive processing on the pain experience (Pud & Sapir, 2006).
Dobek, Beynon, Bosma, and Stroman (2014) investigated the neural mechanisms
underlying music-induced analgesia using fMRI. Noxious thermal stimulation was
applied while subjects listened to their favourite music, or no music. Subjective pain
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ratings were recorded while the spinal cord, brainstem and brain was scanned. In
both the pain and pain with music condition neural activity was noted in areas
consistent with previous experiments involving pain perception, however the pain
with pleasurable music condition also involved activity in the limbic, frontal and
auditory regions. This condition also demonstrated activity in the regions involved in
the descending pain modulatory system, namely the dorsolateral prefrontal cortex
(DLPFC), PAG, RVM, and the dorsal grey matter of the spinal cord. This gives a clear
indication of the connections between auditory and pain perception and helps to
explain the mechanisms underlying music-induced analgesia; namely activation of
the descending inhibitory pathways.

2.6.4 Modulatory effects of olfaction on pain perception.

Raudenbush, Koon, Meyer, Corley, and Flower (2004) investigated whether odours
could modulate subjects’ pain ratings and pain tolerance levels. Via a nasal cannula,
they exposed the subjects to low-flow oxygen, peppermint odour plus oxygen, or
jasmine odour plus oxygen while they underwent a cold pressor test. Subjects
reported pain levels using a 0-10 scale every 30 sec, up to a maximum of 5 minutes.
Following the cold pressor test, subjects also completed questionnaires related to
mood (POMS), workload (NASA-TLX), and anxiety (STAI). The results indicated that
peppermint and jasmine odour significantly decreased ratings of pain and increased
overall pain tolerance. The questionnaires clearly reported positive influences by the
odour conditions on the mood, workload and anxiety levels of subjects. Physiological
changes were also observed. Oxygen saturation levels improved, pulse rate increased
and blood pressure decreased during odour administration (Raudenbush et al.,
2004).
The positive effects of odour on pain intensity ratings were supported by a recent
study by Bartolo et al. (2013). They used the nociceptive withdrawal reflex (NWR), a
defensive, protective response to a noxious stimulus as a reliable indicator of spinal
nociception in humans, to explore the modulatory effects of odour on pain
perception. They compared a pleasant odour, an unpleasant odour and a neutral
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odour. The results indicated that both the NWR magnitude and subjective pain
ratings were reduced by odours evoking pleasant sensations and increased by odours
evoking unpleasant sensations. From this experiment, the investigators were unable
to establish whether olfactory-modulation of pain exists as a result of direct
connections between the primary olfactory enthorhinal cortex and spinal cord
neurons or whether the modulation occurs indirectly by cognition, mood, anxiety,
emotion, memories (Bartolo et al., 2013).
A separate investigation aimed to establish whether odour-analgesia was related to
hedonics of pleasantness or to a quality of the odour, specifically sweetness. The
researchers assessed the effects on pain ratings and pain tolerance during application
of a sweet-smelling odour, a pleasant odour, an unpleasant odour, and no odour.
Again pain was evoked using a cold pressor test. The results indicated that odour
sweetness rather than pleasantness increased pain tolerance. This may be through
associative learning, through the frequent pairing of odours with sweet tastes. These
results, however, dispute the findings of the above-mentioned studies in that odour
itself was found to have no effect on pain intensity ratings. (Prescott & Wilkie, 2007).

2.6.5 Modulatory effects of gustation on pain perception.

Variable results have been observed when the modulatory effect of gustation on pain
has been explored. This is particularly evident when the results of studies involving
infant populations are compared to adult populations.
In an experiment on newborns undergoing heel-stick procedures, pain was measured
under four gustatory conditions: (a) water-moistened pacifier, (b) sugar-coated
pacifier, (c) 2 cc of a 12% oral sucrose solution, or (d) control. Pain measures were
duration of cry, vagal tone, and salivary cortisol levels. The results indicated that the
babies with the sugar-coated pacifiers cried significantly less and they demonstrated
significantly lower vagal tone than the babies in the other conditions. This difference
was observed for fifteen minutes after the procedure. This suggests that the
concentrated form of sucrose in the sugar-coated pacifier possibly modulated the
pain experience. We cannot attribute the findings to the pacifier because one of the
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other conditions involved the use of a water-moistened pacifier, which made no
significant difference (Greenberg, 2002). That the 12% oral sucrose solution didn’t
have a significant analgesic effect is likely to be due to the differences in
concentration between the sugar-coated pacifier and the sucrose solution. The
results from a review of studies examining the analgesic effects of sweet-tasting
solutions for infants concurred with these findings (Harrison, Bueno, Yamada, AdamsWebber, & Stevens, 2010).
Contradictory results are observed when the analgesic effect of sucrose is studied in
adults. A more recent study compared modulatory effects of sweet, bitter and
tasteless gelatine in the mouth of subjects who had experimental jaw muscle pain
evoked by injection of hypertonic saline into the masseter muscle. The subjects
continuously rated pain intensity as well as mood and unpleasantness/pleasantness
of the conditioning stimuli. The gustatory stimuli failed to generate a robust change
on the scores of emotions. No effects on pain intensity were observed during sweet
or bitter gustatory stimuli. Based on pre-existing knowledge that emotions have an
important modulatory effect on pain perception, the investigators concluded that the
lack of pain intensity modulation during exposure to varied tastes was likely due to a
lack of modulatory effects of gustation on emotions and the limbic system, and
subsequently on the pain experience (Horjales-Araujo, Finnerup, Jensen, & Svensson,
2013).
2.6.6 Modulatory effects of vision on pain perception.
2.6.6i Modulatory effects of vision on pain perception in a healthy
population.
Anticipation of pain in response to a visual stimulus appears to have a modulatory
effect on perceived pain. Visual input in peripersonal space modulates neural
processes involved in predicting pain. One study showed that pain unpleasantness
ratings were higher when the subject observed a needle approaching an embodied
artificial hand, as opposed to a Q tip approaching the hand. The researchers felt the
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expectation of pain was likely to have been responsible for the subjects’ increased
pain unpleasantness perception (Höfle, Hauck, Engel, & Senkowski, 2012).
A study by Martini, Perez-Marcos, and Sanchez-Vives (2013) showed that pain
thresholds to a thermal stimulus were modified by changing the colour of an
embodied virtual arm between blue, red and green. The subject’s pain threshold was
lower when the virtual image was seen as red compared with when it turned blue.
The visual input had a significant modulatory effect on the perceived pain which the
investigators attributed to a top-down cognitive process of understanding the
meaning of the visual input i.e. that red is associated with warmth and blue with cold.
When the noxious thermal stimulus was associated with a red visual cue it was
perceived as being hotter and hurt more than when the same stimulus was
associated with a blue cue.
Visualisation of one’s own body part while a painful stimulus is applied is a form of
multisensory modulation which has attracted a lot of attention recently. The intensity
of perceived pain can be affected by the content of visual input. In a study by Longo
et al. (2009) subjects looked into a mirror aligned with the midline of their body at
either a reflection of their left hand, another person’s left hand or at a reflection of a
neutral object. The reflection of their left hand created the illusion that they were
observing their right hand. The use of the mirror enabled the investigators to apply a
painful stimulus to the right hand while the subject observed the illusion of their right
hand but without the subject actually observing the application of that stimulus. In
other words, the stimulus remained “non-informative”. After a 60 second induction
period where the subject looked passively at the object reflected in the mirror, laser
stimulation was used to selectively activate the nociceptive A Delta and C fibres,
without activating mechanoreceptive afferents. Subjective pain ratings, using the
VAS were collected while the stimulus was applied to compare any differences
between visualising the painful body part and visualising a neutral object. A
questionnaire was administered following each testing condition to determine what
exactly the subject felt they were looking at in the mirror. Both the subjective ratings
of perceived pain by the participant to cutaneous laser stimulation and the maximum
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level of laser stimulation achieved reflected a reduction in perceived pain when the
participant viewed their own hand, in contrast to viewing a neutral object. A variation
of this experiment was included in the study where another person’s hand was
reflected in the mirror instead of the subject’s. This part of the experiment
demonstrated that the analgesic response is specific to observing one’s own hand, as
opposed to another person’s hand. A second variation was also included which
involved the subject looking directly at the right hand or at an object rather than a
reflection of the left hand or object respectively. This part of the experiment was
included to investigate the proposed mechanism underlying the analgesic effect; that
of conflicting proprioceptive, sensory and visual representations produced by the
mirror inhibiting pain. When the mirror was removed, the analgesic effect was still
noted. The researchers therefore excluded this mechanism as the possible
explanation behind the analgesic effect (Longo et al., 2009).
It appears that pain and touch respond in contrasting ways to non-informative vision
of a body part during noxious stimulation. Non-informative vision of the hand
increases tactile acuity (Kennett, Taylor-Clarke, & Haggard, 2001), while in the
experiment by Longo et al. (2009) pain ratings were lower with non-informative
vision of the body part during noxious stimulation. A proposed explanation by Longo
et al. (2009) for their experimental observations involved the visual-activation of
GABAergic interneurons. GABA is a major neurotransmitter within the descending
inhibitory system, thereby reducing perceived pain as a result of cross-modal
modulation/inhibition. They cited the work of Kennett et al. (2001) who reported
enhanced tactile acuity by visual modulation of somatosensory GABAergic
neurotransmitters. Thus, they suggested that GABAergic interneurons are a likely
effector of both improved tactile acuity and analgesia during this non-informed vision
of the body part (Longo et al., 2009).
It is also proposed that visual perception of one’s own body results in functional
coupling between visual and parietal areas that may subserve multisensory inhibitory
mechanisms. Longo, Iannetti, Mancini, Driver, and Haggard (2012) investigated the
neural correlates underlying visual analgesia. They used fMRI to assess the neural
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activity of the brain during the visual analgesia phenomenon that they had previously
described. They used an infra-red laser to stimulate the cutaneous nociceptors of
normal subjects’ right hands, under two conditions. They compared the subjective
pain ratings and the regional brain activity, while the subject was stimulated looking
at a neutral object versus looking at their own hand. The visual analgesic effect was
confirmed with analysis of the subjective pain ratings. The fMRI clarified the regions
of the brain associated with visual perception, namely the bilateral posterior parietal
cortices (PPC), lateral occipital and superior parietal cortices. Extensive activations
bilaterally within the S1, S2, anterior insula, posterior insula, ACC and midcingulate
cortex were observed during pain stimulation compared to a resting state. Therefore,
there was little overlap between this and the pattern of activation noted during the
visual perception. One common region that was activated in both scenarios,
however, was the basal ganglia, particularly the caudate nucleus and the putamen.
Thus the basal ganglia may provide the link between the visual system and
nociceptive system to allow for pain modulation and subsequent visual analgesia.
Their findings suggest that visually-induced analgesia does not result from a
reduction in overall cortical responses to the painful stimulus but rather appears to
be as a result of the activation of visual or bimodal visuo-tactile cells in the secondary
somatosensory cortex (posterior parietal cortex). The investigators propose that
sensory input such as vision causes these cells to activate inhibitory interneurons in
the early somatosensory areas (S1 and thalamus) - regions associated with the
perception of pain. This was evident from the increased connectivity (i.e. functional
coupling) observed between posterior parietal nodes of the visual body network and
the structures comprising the pain matrix such as SII, anterior and posterior insula,
and anterior cingulate cortex. This appears to occur much more quickly than the
structural reorganizational changes associated with the development of chronic pain.
Importantly, the pain experience was shown to be an emergent result of connectivity
between multiple regions of the brain, rather than a direct read-out of nociceptive
stimulation, within a specific pain matrix.
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In 2015 Valentini et al. (2015) found that a vision induced analgesic effect was only
observed when the viewed body part was placed across the midline. Direct vision of
the hand (as opposed to the mirror-box used in the study by Longo et. al. (2009)) in
an uncrossed position alone and crossing the midline alone did not induce an
analgesic effect, while together they did influence the intensity of the pain perceived.
The analgesic effect observed with vision of one’s own body in a crossed position may
be due to the augmented cognitive processing required to resolve the conflict
between body-centred representation of the visual input and the egocentric spatial
frame of reference. This would suggest that a combination of mismatched
proprioceptive and visual representations may be worth incorporating into a pain
management plan.
Torta et al. (2015), suggested that the mirror-box, that was used in several previous
studies to avoid the confounding effect of viewing the noxious stimulator, may
contribute to the reported visual analgesia. They used a heat laser stimulator on the
skin of the hand to compare the effects of “direct” vision of the hand versus vision of
an illusion of the hand via a mirror-box on the intensity of pain ratings and on the
event-related potentials (ERPs) elicited by nociceptive and non-nociceptive stimuli.
They were unable to demonstrate visual analgesia or any effect on pain
unpleasantness when viewing the hand either directly through a glass panel or a
mirror-image of the hand, compared to when viewing a neutral object. They ruled
out the possibility of the interposed glass causing the lack in observed visual analgesia
by repeating the experiment. They compared pain ratings when observing the hand
directly as opposed to through the glass panel and there was no significant difference
observed. However, they did observe greater nociceptive ERPs during vision of a
neutral object compared to the hand, and greater non-nociceptive ERPs during vision
of the hand compared to a neutral object. The researchers stated that the changes
in brain activity were unlikely to be linked to the concept of “visual analgesia”
reported by Longo et al. (2009), as there was no change in perceived intensity
observed in this experiment. This study raises further questions about what specific
factors need to be in place to bring about visual analgesia.

44

2.6.6ii Modulatory effects of vision on pain perception in a clinical
population.

There are some indications that clinical pain may be subject to some of the same
integration across multi-sensory modalities as seen with experimental pain. Wand et
al. (2012) used a mirror with lower back pain patients to allow them to view their
backs during pain-provoking lumbar spine movements. The view of their backs during
movement proved to have an analgesic effect, demonstrating that visual analgesia
potentially exists for clinical pain. The researchers did not investigate if magnification
or minification of the viewed body part affected the analgesia.

Diers et al. (2015) supported these findings in a chronic back pain population. Using
real-time video feedback, subjects’ perceived pain intensity was reduced compared
to viewing a neutral object, a video of another person of the same sex’s back or a
static picture of their own back. The authors cited Longo et al. (2009) to explain their
results, suggesting that the increase in the sense of agency by monitoring the painful
body part would augment the subject’s body awareness potentially giving rise to topdown pain reduction. There was no significant difference in reported pain
unpleasantness. Interestingly, an analgesic effect was also noted when the subjects
were tested with their eyes closed, however the authors feel that there were likely
to be two different mechanisms underlying these effects. In conclusions, Diers et al.
(2015) proposed that real-time video feedback of movement could be a simple and
beneficial treatment modality to incorporate into the management plans of chronic
pain patients.

Visualisation was also documented to have an effect in a paper which describes a
study, focussed mainly on improving two point discrimination (TPD) training success.
Moseley and Wiech (2009) explored the effects of coupling visualisation of the painful
body part with TPD training in a CRPS population, as opposed to TPD training alone.
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Using a mirror-box to reflect the unaffected arm, there was a greater reduction in
TPD threshold and pain levels post-training in the visualisation condition compared
to the controls, however only the TPD difference lasted until the 2 day follow-up
measurement. The pain relief was short-lived.

2.6.6iii Effects of visual distortion of size on pain perception in a healthy
population.
Exploration of the effects of visual distortion of size on perceived pain has also gained
momentum recently. Mancini et al. (2011) measured heat-pain threshold changes to
assess the effect of visual analgesia under three different visual conditions. A mirror
box was used to create the illusion of the ipsilateral hand, while that hand was
stimulated with a thermal laser behind the mirror. In this experiment the visual
condition was altered by replacing the normal mirror with a convex or concave mirror
to produce a magnified or minified reflection respectively. The subjects were given a
10-minute adaptation period in which they focussed on the reflected image. A fake
laser probe was applied to the reflected hand to prevent perceptual conflict.
Questionnaires were used after each condition to check that the mirror had induced
the illusion of the hidden hand, that the various mirrors were effective in generating
variances in the perceived size of the reflected hand and to monitor base skin
temperatures. Pain threshold was assessed by asking subjects to press a pedal at the
moment the heat stimulus became painful. This same experiment was then repeated
but the hand to be reflected was placed inside a wooden box, so the reflected image
was a neutral object instead of their hand, and the three visual conditions repeated
again. The results of these experiments confirmed the findings of non-informative
visual analgesia which was established in the previous experiment. But this
experiment went on to show that visual enlargement of the hand enhanced analgesia
and visual reduction of the hand decreased analgesia. This suggests a dose-response
relationship to analgesia. With magnification of the perceived size of the body part,
there was an increased analgesic effect, and vice versa.
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A distinctive difference between the methods of pain ratings collected in this
experiment and those used by Longo et al. (2009) is that the subjects had to push a
pedal the moment they perceived the stimulus as painful, while Longo et al. (2009)
used VAS pain ratings. These ratings would be generated after potential modulation
by cognitive, emotional and multisensory influences but the pedal mechanism better
isolates the sensory-discriminative component of the pain before modulation comes
in to play. Despite this, similar effects were observed, which demonstrates that
visualising the body part modulates the sensory-discriminative component of the
pain experience in the early somatosensory areas (Mancini et al., 2011).
One explanation for the mechanism underlying non-informative visual analgesia and
for the increased analgesic effect noted when the body part is magnified is that there
is increased attention turned toward the body part, which would have cognitive
modulatory (inhibitory) effects on the pain experience. However, that a reduction in
analgesia is observed in the minified condition disputes this as there is also likely to
be increased attention drawn towards a body part that is viewed as unusually small.
Osumi et al. (2014) showed that visual analgesia and analgesia due to visual distortion
of size of the affected body part are not necessarily standard responses. They
explored the factors associated with modulation of pain by using the magnifying
mirror-box technique employed by Mancini et al. (2011). Subjects were divided into
two groups according to their pain threshold responses to the magnified condition.
Subjects who displayed a higher threshold to the thermal stimulus also displayed
more vivid somatosensory perception (two-point discrimination) and presented with
a neutral emotional response to the view of the magnified hand. Subjects who
displayed a lower pain threshold in response to the magnified condition were
separated into the “low-threshold” group and this response was found to be
associated with no significant difference between TPD in actual and enlarged size
conditions, and with a more negative impression of the magnified image of the hand
compared to the “high threshold” group. There was also a strong negative correlation
between the differences in feelings towards the enlarged hand and the Body Attitude
Questionnaire (BAQ) scores in both conditions.
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While interesting and compelling, these above-mentioned studies were performed
on healthy populations, using experimentally-induced cutaneous pain. The
methodology employed only inflicted noxious stimuli in superficial structures. Most
clinical pain presenting to physiotherapists are likely to be contributed to by noxious
input from deep tissues (Bove et al., 2005), so exploration of the effects of visual
distortion of size on deep tissue pain and clinical pain conditions is important.

2.6.6iv Effects of visual distortion of size on pain perception in a clinical
population.
An exploratory experiment, using real-time video capture of subjects’ hands, was
able to manipulate the perceived size of painful and non-painful parts of the hand in
an attempt to modulate pain experienced by twenty osteoarthritis sufferers (Preston
& Newport, 2011). The study demonstrated that both stretching and shrinking the
painful parts of the hand had an analgesic effect, halving the pain in 85% of the
subjects. This effect was not witnessed when the entire hand or non-painful parts
were stretched or shrunk (Preston & Newport, 2011). It is interesting that the
analgesic effect was observed in both the shrunken and enlarged conditions. The
authors propose that two distinct mechanisms could underlie these two effects, with
the possibility that placebo could play a role in them. This research demonstrated
that visual distortion of size has a modulatory effect on perceived clinical pain and
that the use of visual illusions created using real-time video may be a potentially
beneficial form of treatment for chronic pain sufferers.
A study by Moseley et al. (2008) revealed contrasting effects of visualisation and
visual distortion of size in a clinical population of subjects with CRPS of a unilateral
upper limb. Under four visual conditions, a small sample size of ten subjects watched
their painful arm while they performed a program of ten hand movements at a predetermined and standardised speed and amplitude. The four conditions involved
looking at their arm: 1) normally, 2) through clear glass, 3) through magnifying
binoculars, and 4) though minifying binoculars. The results indicated that the
48

magnified view of the limb significantly increased the perceived pain and extended
the time for return to resting pain levels. Pain was least when they viewed the
minified image of their arm during movements and recovery to pre-task pain was
quickest under this condition (Moseley et al., 2008).
Working with an upper limb amputee suffering from significant phantom limb pain
Ramachandran et al. (2009) were able to alleviate the phantom sensation and
phantom pain of the elbow, wrist and proximal palm leaving the distal palm and digit
pain unaffected. This was achieved by the subject attempting to perform symmetrical
movements of both upper limbs while observing a reflection of the intact limb in a
mirror-box. They explored changing the perceived size of the phantom limb with
magnifying and minifying lenses, and found that magnification condition made no
difference to the resting phantom pain, while shrinking the size of the phantom limb
dramatically reduced the perceived pain. When the subject shut his eyes his pain
returned immediately. This experiment confirmed in a clinical population the “visual
analgesic” effect proposed by Longo et al. (2009) however, as reported by Moseley
et al. (2008) the effects of visual distortion of size were in contrast to those found by
Mancini et al. (2011). Perhaps the difference lies in the clinical pain populations
studied.
Several significant differences exist between chronic and acute pain mechanisms
(Phillips & Clauw, 2011). These may explain the different findings. In CRPS subjects
the size and territory of the brain region which represents the affected limb has been
seen to change (Lewis et al., 2007). Also, an impaired body image and sense of
ownership have been linked to chronic pain syndromes (Lewis et al., 2007). These
findings may well underlie the variances in effects noted. An alternative explanation
may be the significant differences which appear to exist between superficial and deep
tissue pain. Comparison between superficial and deep pain mechanisms is therefore
warranted and necessary.
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2.7

Deep versus Superficial Pain

Pain that arises from noxious stimulation of deep tissues appears to be quite different
to pain that arises from noxious cutaneous stimulation, not only subjectively but also
from a neuroanatomical and mechanistic perspective.
Witting, Svensson, Gottrup, Arendt-Nielsen, and Jensen (2000) compared pain from
noxious skin stimulation to pain from noxious muscle stimulation, using equal stimuli
of capsaicin. This study showed that cutaneous pain varied significantly to
intramuscular pain in several ways. They found the quality of cutaneous pain to be
commonly described as sharp, while muscle pain to be described as dull, throbbing,
and less intense. Cutaneous pain tends to be well localised which is important for
protection. A fast motor response can often remove an external noxious stimulus.
Muscle pain was observed to be less localised (Witting et al., 2000). A separate study
noted that while muscle pain is difficult to localise, pain arising from other deep
structures, such as periostea and fascia was actually well localised (Staff, 1988).
Peripherally, if the stimulus is strong enough, muscle pain can result in referred pain
to subcutaneous structures distant to the site of the stimulus and the muscle being
stimulated, while superficial pain does not demonstrate this phenomenon (Witting
et al., 2000). Viscera were also shown to refer pain, however they appear to refer
pain only to the skin (S Mense & Simons, 2001). Another observation was that the
pain experience was reported to last longer when muscles are stimulated compared
with when superficial tissues are exposed to the same painful stimulus (Witting et al.,
2000).
At the spinal level, muscular pain differs from cutaneous pain in that the excitatory
effects of unmyelinated A Delta afferent fibres from muscle are subject to a strong
segmental inhibition by myelinated A β afferent fibres. This inhibition is not observed
with activation of the cutaneous C fibres (S. Mense, 2003).
In the central nervous system, nociceptive signals from muscle and skin are processed
differently. The afferent nociceptive fibres from muscular tissue terminate in the
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ventral PAG while those from the skin terminate in the lateral PAG (Keay & Bandler,
1993). A separate study showed there is not one specific region in the brain activated
by muscle pain however the S2 was specifically activated by nociceptive cutaneous
stimuli (Uematsu, Shibata, Miyauchi, & Mashimo, 2011). These differences that have
been observed in the processing of superficial and deep nociception may explain the
variance seen in the descending modulation of deep and superficial nociceptive
signals.
Activity in the descending pain-modulatory pathways was found to influence the
superficial and deep tissue nociceptor afferents differently. Spinal neurons with
afferent input from deep tissues were observed to be located in the superficial dorsal
horn and in and around lamina V, and were more strongly affected by the descending
inhibition than cutaneous input to the same neuron (Yu & Mense, 1990). It was also
observed that when descending pain-modulating pathways were experimentally
interrupted, the observed activity in the ascending nociceptive pathways distal to the
site of interruption is not equal between the cutaneous and deep nociceptor
afferents. The activity was higher in neurones with input from deep nociceptors than
in cells mediating cutaneous nociception (S. Mense, 2003). The two mechanisms are
affected differently when descending inhibition is disrupted.
These differences demonstrate why the findings of experiments involving
cutaneously-induced pain should not be directly applied to deep tissue pain. It
appears that deep tissue and superficial tissue mediated pain mechanisms are
considerably different from each other.
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2.8

Summary of Literature Review

Over the past four decades, our concepts of mechanisms underlying pain have
evolved radically to the point where we now believe pain to be a complex interaction
of multiple inputs creating a subjective, multidimensional, emergent experience
(Breen, 2002).
Nociceptors are sensory receptors that detect noxious stimuli. They respond to
extreme and potentially damaging mechanical, thermal and chemical stimuli. The
dorsal horn of the spinal cord is the ultimate target and relay station for the primary
nociceptive afferents and the impulses conveyed by them. Despite the distinct
laminae within the dorsal horn, there are branched collateral connections which are
likely to allow for ‘cross-talk’ between nociceptive and non-nociceptive afferents at
this level. It is thought that these potential connections may play a role in pain
modulation (Basbaum & Jessel, 2000).
According to Basbaum and Jessel (2000) there are regions in the cerebral cortex
which respond exclusively to nociceptive input. However a review by Legrain et al.
(2011) disputed this and proposed that the areas that were once thought of as
nociceptive specific are better thought of as salient specific. Nociception is just one
of many types of salient information that gives rise to a particular salient specific
neurosignature. ERPs elicited in response to a salient stimulus involve three
processes, namely the detection, localisation and reaction to the salient and
potentially dangerous physical threat
Nociceptive input is modulated by various factors at various levels which can allow
for the production of a very different pain experience which is not only reflective of
what is occurring at the tissue level. Modulation appears to occur in the periphery at
the nociceptor terminals, within the laminae of the dorsal horn, and in supraspinal
centres.
Besides evidence of the influence of cognition and emotion on our perception of pain,
the intensity of pain may be influenced by the interaction from other sensory
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modalities, such as tactile, nociceptive, auditory, olfactory, gustatory, and visual
input. This phenomenon is known as multisensory modulation (Haggard et al., 2013).
There has been significant interest in exploring the influence of multisensory
integration on the pain experience, particularly vision, over the past several years.
Longo et al. (2009) showed that observation of the actual body part while an unseen
painful stimulus is applied topically to that body part has an analgesic effect, as
opposed to observation of a neutral object. They adopted the term “non-informative
analgesia” as the stimulus is not visualised. This experiment was carried out in a
healthy population.
Wand et al. (2012) used a mirror with lower back pain patients to allow them to view
their backs during pain-provoking lumbar spine movements. The view of the subjects’
backs during movement proved to have an analgesic effect.
Diers et al. (2015) supported Wand et al. (2012) findings by observing visual analgesia
in a chronic back pain population, demonstrating that the intensity of perceived back
pain could be reduced by subjects simply watching their backs on a video screen.
However, Torta et al. (2015) did not observe visual analgesia when subjects viewed a
mirror image of their hand or their hand directly, when compared to a neutral object.
Valentini et al. (2015) recorded an analgesic effect only when viewing the hand was
combined with the hand crossing the midline. No analgesia was experienced with
visualisation alone in their study.
The effects of visual distortion of body size on pain perception have also been
explored, with mixed results. Mancini et al. (2011) proposed a dose-response
relationship to visual analgesia. With magnification of the perceived size of the body
part an increased analgesic effect was observed whereas minification of the body
part reduced the analgesic effect. Preston and Newport (2011) also reported a
significant analgesic effect when the size of the view of the painful part of the hand
in osteoarthritic sufferers was altered using real-time video.
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More recent findings by Osumi et al. (2014) have suggested modulation of pain by
visualisation is not a definitive response and is associated with certain conditions
being in place. They found that subjects’ somatosensory vividness (TPD) was reduced
and a neutral emotional response was displayed by the subjects who demonstrated
a higher pain threshold in the enlarged condition compared to the actual size
condition. Subjects with strong obsessiveness towards the shape and appearance of
their own bodies (as reflected by the BAQ scores) displayed negative feelings towards
the magnified mirror visual feedback and these factors were found to be associated
with a reduction in pain threshold in the magnified condition.
These articles suggest that visualisation, and particularly visual magnification of the
painful body part might have some therapeutic value in the management of clinical
pain states, although findings by Moseley et al. (2008) and Ramachandran et al.
(2009) in CRPS patients and phantom limb pain patients respectively contradict
these. They observed a modulatory effect of visual distortion of size however this was
in the opposite direction to Mancini et al. (2011). Mechanisms underlying these two
unique chronic pain syndromes may, however, operate differently and account for
the different results observed.
The studies by Longo et al. (2009), Mancini et al. (2011) and Osumi et al. (2014)
involved the application of noxious stimuli to the skin of subjects. It is thought that
most clinical pain is contributed to by noxious stimuli from deeper tissues. Despite
this, to date there have been no studies researching the effects of visualisation and
visual distortion of size on experimental deep tissue pain. These questions are the
topic of this thesis:
1. Does visualisation of the painful body part have an effect on deep tissue pain?
2. Will pain perception be modified by visual distortion of the size of the viewed
quadriceps muscle, in the form of magnification?
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CHAPTER THREE: PILOT STUDY

This study investigated the stability of the outcome measures used to assess

experimental deep tissue pain in the form of Delayed Onset Muscle Soreness (DOMS).
We also required data obtained from the pilot study to inform the power calculation
for the primary study.
Eccentric exercise is a well-established method of inducing deep tissue soreness
(Cheung, Hume, & Maxwell, 2003; Law et al., 2008). The exact mechanisms
underpinning the pain experienced are not yet fully described, however DOMS is
viewed as the perceptual correlate of a muscle adaptive process (Malm, 2001)
induced by a novel bout of loaded, lengthening eccentric contractions. Typically
delayed soreness peaks between 24 and 48 hours post exercise reaching complete
resolution by day five to seven post exercise (Abraham, 1977)
While DOMS as an endogenous model of deep tissue pain has been widely used as
an experimental methodology utilised to investigate deep pain, there is a dearth of
information regarding the stability of the pain responses evoked during DOMS
perception. Currently there are no data on the temporal reliability of the pain
responses to movement or mechanical stimulation. This study therefore investigated
the reliability of repeated evoked pain responses (over the course of 1 hour) to a
standardised contraction in a DOMs affected muscle. Further, this pilot study
provided data that informed the power calculations of the main study project.
Observation over the period of one hour was chosen as this was anticipated to be the
length of time required for the testing procedure in the second session of the primary
study. If the intensity of pain was demonstrated to remain constant then any changes
in intensity experienced in the second session of the primary study could not be
attributed to time and could therefore be attributed to the various visual conditions
experienced by the subjects.
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3.1

Study Design and Methodology

A repeated-measures within-subjects design was used in this pilot project. Ethics
approval was obtained from the HREC of The University of Notre Dame Australia
(Reference number: 014036F) and all participants provided written informed
consent.
DOMS was induced in either the left or right quadriceps muscle of involved
participants. A key feature of the primary study in this project was the requirement
to be able to observe the sore body part. Quadriceps and forearm extensors were
therefore considered ideal in this regard (as opposed to Triceps or Gastrocnemius for
example). Test exercise revealed inconsistency in the level of DOMS induced in the
forearm muscles, therefore this study focussed on DOMS in quadriceps muscle. The
non-dominant limb was chosen for DOMS induction to standardise our procedure
and also because the non-dominant limb was likely to be less conditioned than the
dominant limb and hence yield more consistent delayed onset soreness responses.

3.1.1 Participants.
Ten healthy volunteers participated in this project. The researchers worked directly
within their personal networks to identify individuals to participate in this study.
Inclusion criteria for the pilot study: aged between 18 and 50 years, proficient in
written and spoken English and the ability to provide informed written consent.
Participants were excluded if they suffered ongoing lumbar spine problems,
experienced abnormal tenderness to palpation of the soft tissues of the thigh,
presented with reduced or excessive knee or hip movement, had suffered leg pain
that required a visit to a health care professional within the previous 12 months or
had sustained a fracture or dislocation of the leg within the last five years. They were
also excluded if they had any ongoing medical or neurological conditions, consumed
regular anticoagulant medication or medications known to influence pain sensitivity
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(e.g. painkillers, anti-inflammatories, anti-depressants) or if they had recently trained
the quadriceps with eccentric strength exercises (within the previous six months).

3.1.2 Experimental procedure.
Each subject attended two sessions 48 hours apart.

Session one.
The purpose of the 1st session was to collect subject demographics and to guide the
subject through an exercise protocol which had been developed to induce DOMS in
the non-dominant quadriceps muscle.
At the first visit, subjects received a Plain Language Statement which explained the
process of the study and the implications of their participation. Informed consent was
obtained and basic demographic information collected. The procedure of the study
was explained, the subject’s maximal isometric knee extension strength was
determined, and they were then supervised in a one-on-one manner by the
researcher through the exercise protocol aimed at inducing DOMS.

3.1.2i Maximal isometric knee extension strength.
The participant’s maximal isometric strength of the non-dominant quadriceps muscle
was established. This was performed with the subject in a seated position with knees
and hips flexed to 90 degrees and feet flat on the floor. The subject extended the
non-dominant knee until they were at a point 10⁰ off full knee extension. The
assessor then positioned a hand-held dynamometer against the anterior aspect of
the distal tibia, just proximal to the talo-crural joint line. The subject was asked to
attempt to extend the knee into full extension while the assessor resisted this action,
resulting in a maximal isometric contraction. Once the dynamometer registered the
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greatest force generated during the contraction the machine produced a “beep”
sound which indicated the reading had been taken and the subject could relax. This
was repeated 3 times to ensure consistency, with the average of these three scores
being used to establish the sandbag weights required for resistance in the testing
session (see “Testing procedure”).

3.1.2ii Exercise protocol to induce DOMS.
The participants undertook a protocol aimed at inducing DOMS in the non-dominant
quadriceps muscle group. This involved the subject performing 150 repetitions,
leaning backwards as far as possible in a slow and controlled manner from a half
kneeling position (see Figure 1), then returning to the start position with assistance
from the researcher.

Figure 1. Exercise starting position
This figure illustrates the half kneeling position assumed during DOMS-inducing exercise
session.
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The direction and speed of the backward lean was controlled by eccentric
lengthening of the quadriceps muscle on the side the subject was kneeling on. The
researcher acted as a ‘spotter’ during the eccentric component of the task to ensure
safety. The 150 repetitions were divided into five sets of 30 repetitions, and the 30
repetitions were performed as three sets of ten. Subjects had a 30 second break
between each set of ten repetitions and a two-minute break between each of the five
sets.

Plain language statements sent by email to subject prior to first session
↓
Arrival of subject at first session
↓
Procedure of session explained verbally
↓
Written consent obtained, demographics collected
↓
Maximum isometric quad strength at -10⁰ off full extension established
↓
Exercises completed

Figure 2. Flow diagram to represent sequence of events at subjects’ first visit.

Session two.
The 2nd session took place 48 hours later. The purpose of this session was to
determine subject eligibility to participate in the study and to assess the levels of pain
evoked at 15 minute intervals with a view to establishing the stability of the outcome
measures used to assess experimental deep tissue pain in the form of DOMS.
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Subject’s completed a validated Likert scale and then, if included in the study,
underwent the testing procedure.

3.1.2iii Likert scale.
Upon arrival at the 2nd session, 48 hours later, subjects were asked to complete a
previously validated Likert scale of delayed onset muscle soreness that recorded their
perception of soreness experienced at that moment in time (see Appendix 3 for the
full data Collection template) (Slater, Arendt-Nielsen, Wright, & Graven-Nielsen,
2005). They needed to score ≥ 3 to be included in the testing procedure.

1

A light soreness in the muscle felt only when touched/ a vague
ache

2

A moderate soreness felt only when touched/ a slight persistent
pain

3

A light muscle soreness while walking up and down stairs

4

A light muscle soreness when walking on a flat surface

5

A moderate muscle soreness, stiffness or weakness while walking

6

A severe muscle soreness, stiffness or weakness that limits my
ability to move
Figure 3. Modified Likert Scale of muscle soreness
(Andersen, Arendt-Nielsen, Svensson, Danneskiold-Samsøe, & Graven-Nielsen, 2008). This
scale was used by each subject to reflect their level of soreness at the second session.

3.1.2iv Testing procedure: evoked pain during DOMS.
The testing involved the subject performing quadriceps contractions at 15 minute
intervals across the period of one hour and rating the pain evoked by these
standardised contractions. Pain was rated using a numerical rating scale (NRS).
Immediately following each standard contraction the participant was shown a 10cm
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long NRS with zero anchored by ‘no pain’ and 10 with ‘maximum pain’. Participants
provided one NRS score following each contraction. Participants were placed in a
seated position; feet flat on floor, hips and knees flexed to 90°. The load for each
subject was standardised by calculating 40% of the average force recorded during the
maximal isometric contractions completed during session one 48 hours previously. A
sandbag of this established weight was attached to the distal tibial using a Velcro
strap. The researcher then passively extended the affected knee joint. From this
position the subject was then verbally guided to perform a controlled lowering of the
foot towards the floor, allowing flexion of the knee toward 90° over the period of 3
seconds. This movement required eccentric lengthening contraction of the DOMS
affected quadriceps muscle. This procedure was repeated three times and between
each of the three repetitions the assessor extended the knee passively, returning it
to the starting position of full knee extension. The visual conditions were identical
across each test period in that the subjects looked straight ahead focussing on the
same object during each repetition. After three contractions the sandbag was
removed and the subjects were given a 15 minute washout period. This process was
completed at the 15 minute mark, 30 minute mark, 45 minute mark and 60 minute
mark (four sets of three contractions in total).
If, during the testing process, the subject rated their pain consistently as zero out of
ten on the NRS, then the subject was excluded from the study.
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Subject scored pain according to Modified Likert Scale (appendix 3)
↓

↓

Score ≥3

Score < 3

↓

↓

Included in study

Excluded from study

↓
15′ point: Sandbag attached around distal tibia.
3 submaximal eccentric repetitions performed, subject looking straight ahead.
Subject scores each contraction /10 on NRS
↓
Sandbag removed for washout period
↓
30′ point: Sandbag attached around distal tibia.
3 submaximal eccentric repetitions performed, subject looking straight ahead.
Subject scores each contraction /10 on NRS
↓
Sandbag removed for washout period
↓
45′ point: Sandbag attached around distal tibia.
3 submaximal eccentric repetitions performed, subject looking straight ahead.
Subject scores each contraction /10 on NRS
↓
Sandbag removed for washout period
↓
60′ point: Sandbag attached around distal tibia.
3 submaximal eccentric repetitions performed, subject looking straight ahead.
Subject scores each contraction /10 on NRS
↓
Sandbag removed

Figure 4. Flow diagram to represent sequence of events at subjects’ second visit.
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3.1.3 Ethical considerations.
Experimental induction of pain in human subjects is obviously fraught with ethical
considerations. It is important that any pain induced is transient and does not
represent injury or damage to tissues. In essence, the primacy of benefits
outweighing risks has to be respected.
To fulfil these requirements in this research study it was decided to induce DOMS,
which is a usual response to unaccustomed exercise that includes a preponderance
of eccentric muscle actions.
With any form of exercise, there may be some risk of sustaining a musculoskeletal
injury. The researchers believed that the risk of injury in this case was highly unlikely
due to the type of exercise that was to be performed and the fact that the conditions
would be controlled under the direct guidance of a Physiotherapist. The DOMS would
likely cause some short-term discomfort (peaking at approximately 48 hours) in the
thigh muscles of the non-dominant leg, before starting to dissipate. However
previous research has shown that there are no long-term adverse effects from DOMS;
in fact DOMS has been shown to be of benefit to the musculotendinous unit in the
long-run, and high load eccentric exercise is used in the rehabilitation of common
musculoskeletal conditions such as tendinopathy (Alfredson, 2003). In some cases
and under some conditions DOMS has been shown to be of benefit to the participant
in terms of longer term muscle development and function (Brockett, Morgan, &
Proske, 2001). Thus, while exercise in this study was very specific, it was also very
well controlled with the perception of soreness dissipating within a short period of
time (e.g. maximum of seven to ten days) and protecting the muscle from subsequent
DOMS from the same stimulus for up to six weeks.
Participation in the study was only accepted if there was very minimal risk associated
with undertaking the tests involved and that the participant satisfied the criteria for
participation. The subjects were free to stop the testing and withdraw from the study
at any time and to withdraw any unprocessed data previously supplied.
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If any adverse events arose, the chief-investigator was to arrange Physiotherapy or
Medical management at location which is convenient for the participant at the
expense of the co-investigator. The participant’s condition was to be closely
followed-up and monitored by the co-investigator. There were no foreseeable risks
to the researchers.
The benefit of conducting this research was that a better understanding of the
mechanisms of deep tissue pain would be gained, and this in turn could potentially
contribute to treatment modalities targeting pain. As explained, this knowledge was
gained at very low risk to the subjects. This study received Ethical approval by the
Human Research Ethics Committee of the The University of Notre Dame Australia,
Fremantle (Reference number: 014036F) (Appendix 5).
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3.2

Data Analysis
3.2.1 Exploration of data and tests for normality.

Descriptive statistics were used to present demographic information and pain
intensity scores following each contraction for each condition. Normality of
distribution was assessed by visual inspection of Q-Q plots and further investigated
with Shapiro-Wilk tests for normality. All results were reported as Mean ± SD. A pvalue of <0.05 was considered to represent statistical significance. All data were
analysed using IBM SPSS Statistics 23.0 software. A statistician was consulted to assist
with this process.

3.2.2 Stability of pain scores over the period of an hour.
A one-way repeated measures ANOVA was performed to compare pain scores (NRS)
across the hour i.e. at 15 minutes, 30 minutes, 45 minutes and 60 minutes.

3.2.3 Reliability of pain intensity ratings across the period of an hour.
Temporal reliability of pain intensity across the four trials was evaluated using a twoway mixed model intraclass correlation co-efficient ICC(3,1) with absolute agreements.
Preliminary analyses were performed to ensure no violation of the assumptions of
normality, linearity and homoscedasticity.

3.2.4 Sample size and minimal detectable difference size calculations.

The within-subject difference in mean pain intensity ratings (NRS) across the four
time points was estimated and used as the minimal detectable change in the power
calculation for the primary study.
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3.3

Results
3.3.1 Exploration of data and tests for normality.

A total of ten subjects (three males, seven females) volunteered to participate. The
mean age was 40.5 years ± 2.80. Every participant rated their pain at a level of three
or greater on the Modified Likert Scale at the beginning of Session two (Appendix 3),
which meant every subject could be included in the testing component of the
experiment.
The lowest pain score reported across the four testing sessions was 1 out of 10 and
the highest was 8.5. The mean pain score and standard deviations across the four
contraction repetitions are listed in Table 1 below. Visual inspection of boxplots of
each test occasion indicated no outliers and Shapiro-Wilks test for normality
demonstrated a normal distribution for all tests (p>.05).

Time

Mean ± SD

15 minutes

4.37 ± 2.34

30 minutes

4.10 ± 2.02

45 minutes

4.20 ± 2.26

60 minutes

4.23 ± 2.26

Table 1. Mean and Standard Deviations of NRS pain scores across contractions

3.3.2 Stability of pain scores over the period of an hour.
A one-way repeated measures ANOVA was conducted to determine whether there
were statistically significant differences in NRS rating across the four testing
occasions. Mauchly’s test of sphericity was not significant (p>.05) indicating the
assumptions of sphericity had been met. The NRS ratings did not change significantly
over time (F3,27 = .459, p=.713) with mean pain scores listed in Table 1 above.
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3.3.3 Reliability of pain intensity ratings across the period of an hour.

In the two way mixed model intraclass coefficient calculation with absolute
agreements for the four testing occasions, the sample was deemed the random effect
while the repeated rating by the individual was considered the fixed effect. The
ICC(3,1) =.987 indicated extremely high reliability across the testing occasions.

3.3.4 Sample size and minimal detectable difference size calculations.

Based on data from the pilot study we estimated a within-subject difference in means
of 0.3 on the pain intensity NRS. This was used as the threshold for determining the
minimal detectable change in the power calculation for the primary study. The power
of a cross-over design using a minimal detectable difference of 0.3 achieved 90%
power when a minimum of 17 subjects were recruited, the standard deviation of the
mean difference was 0.34 and the significance level was set at 0.05. It was decided
that we should oversample by three subjects in the primary study to give a total
sample of 20 subjects which would increase the power to 96%.
The results of the power calculations used to establish the required sample size for
the primary study are documented and further explained in the “Results” section of
Chapter Four.

67

3.4

Discussion

This pilot study provided two important contributions to this project and potentially
the wider body of literature in which DOMS as an investigative tool in deep-tissue
pain mechanisms is employed.
Firstly, the reliability of NRS pain intensity scores (to an evoked stimulus) over the
period of one hour was demonstrated. An ICC of 0.987 indicates very high reliability.
This information was crucial to enable valid interpretation of our primary study
results.
On exploration of the literature regarding DOMS, it appears that there have been no
previous studies investigating the within-session reliability of pain outcome
measures. Many studies involving DOMS have investigated the effectiveness of
certain treatment modalities on DOMS; for example the influence of vibration prior
to exercise (Bakhtiary, Safovi-Farokhi, & Aminian-Far, 2007) or the effect of low-dose
pulsed ultrasound administered daily post-exercise (Aytar et al., 2008; Howatson,
Van Someren, & Hortobagyi, 2007). Many studies have been conducted as
randomised controlled trials (RCTs) involving an intervention and a control group,
with pain scores prior to the DOMS-inducing exercise session being compared to pain
scores on consecutive days afterwards up to one week post-exercise. Pressure pain
threshold at specified points along the muscle is a pain outcome measure assessed
in some of these studies (Bakhtiary et al., 2007; Howatson et al., 2007; Olsen,
Sjøhaug, van Beekvelt, & Mork, 2012) . Another outcome measure used regularly is
the visual analogue scales that consists of a 100 mm line with “no soreness” at one
end and “unbearably painful” at the other, or similar, to determine muscle soreness
in response to mechanically-evoked pain. This could be in the form of a stretch on
the muscle (Aytar et al., 2008; Howatson et al., 2007) or use of the sore muscle
(Matsuda, Kan, Uematsu, Shibata, & Fujino, 2015). These outcome measures would
have taken a minimum of a few minutes to assess or observe, and it has merely been
assumed that the pain scores would have remained constant over that testing period.
However this has never been proven. This pilot study has now provided this evidence,
particularly for pain which is evoked mechanically as in this pilot study, which in turn
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assists to validate the results of previous studies which have conducted their testing
over a period of time lasting up to one hour.
Some studies have used eccentric exercise-induced muscle soreness to investigate
properties of a specific muscle group. In a study by Binderup, Arendt-Nielsen, and
Madeleine (2010), the heterogeneity of the development of muscle hyperalgesia
within the trapezius muscle was demonstrated by mapping the pressure-pain
sensitivity throughout the muscle 24 hours after eccentric exercises were performed
to induce muscle soreness. Fernández-Carnero et al. (2010) also mapped
topographical pressure pain sensitivity. In this case it was around the lateral elbow of
subjects who had exercise-induced lateral epicondylalgia in order to help establish
and implicate the extensor carpi radialis brevis muscle belly in lateral epicondylagia.
Whilst threshold values are conceptually separate from evoked pain responses, the
high temporal stability of the pain scores established through this pilot study, add
weight to conclusions drawn from studies involving topographical mapping of various
properties of muscles affected by DOMS.

To date, most studies investigating potential treatment modalities for DOMS have
involved control and experimental groups as opposed to within-subject, repeated
measures designs. Our study has demonstrated reliability of the within-session selfreported pain outcomes, allowing for the use of this design in future repeatedmeasure studies. DOMS is already frequently used as an experimental form of pain
and as research into pain evolves the use of DOMS is likely to escalate as an ethical,
safe and effective form of experimental deep tissue pain. It is therefore imperative
that this reliability has been established for both the currently used RCT designs as
well as potential future repeated-measures within-subject designs.

Secondly, the within-subject mean difference was calculated and used as the
threshold for determining the minimal detectable change for the primary study. This
was established to be 0.3 on a NRS scale. This value was used to assist us in calculating
the sample size required in the primary study. Furthermore it also provides a
threshold value below which changes in NRS may be considered ‘noise’ or natural
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variance between individuals but above which may be interpreted as representing
actual change in scores. Prior to this study, the value of this was largely unknown or
assumed information.

3.5

Conclusion

This pilot study succeeded in establishing the stability of the movement-evoked pain
responses during DOMS perception over the course of one hour. This was imperative
to ensure valid analysis of our primary study data. Furthermore, this contributes to
previous research involving DOMS whereby temporal stability of mechanicallyevoked pain responses during DOMS has previously merely been assumed.
Based on data from the pilot study we estimated a within-subject difference in means
of 0.3 on the pain intensity NRS. This was used as the threshold for determining the
minimal detectable change in the power calculation for the primary study.
Furthermore, this figure could be used in future research as a quantifiable threshold
value to assist in determining significant effect sizes.

The sample size calculation for the primary study was based on a minimal detectable
mean difference of 0.3 and on a standard deviation of the within-subject mean
difference being 0.34. It was established that 17 subjects in the primary study to
achieve 90% power (see section 4.2 for more detail on the sample size calculations).
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CHAPTER FOUR: PRIMARY STUDY

This study attempted to establish whether visualisation of the painful body part has
an effect on experimental pain induced by stimulation of deep tissue, and if so,
whether this was in the direction of analgesia. Secondly, this study explored whether
visual distortion of body size impacts pain perception, specifically magnification of
the viewed body part. Exploration of deep tissue pain is necessary as most clinical
pain is believed to be contributed to by noxious information from tissues deeper than
the skin (Bove et al., 2005). Therefore the results of this study could potentially be
more clinically relevant than the findings of studies involving experimental superficial
pain, upon which our hypotheses were based.
This study has made use of “direct” visualisation of the thigh. For both the condition
involving normal vision of the thigh and the condition involving a magnified view of
the thigh the subject will observe their thigh directly, albeit through magnifying
glasses in the magnified condition. This avoids the use of the mirror box which is the
mechanism that Torta et al. (2015) has proposed to be responsible for the visual
analgesia described by Longo et al. (2009), eliminating this as a potential confounder.
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4.1

Study Design and Methodology

A repeated-measures within-subjects randomised experiment was carried out at The
University of Notre Dame Australia, Fremantle. This study received ethics approval
from the HREC of The University of Notre Dame Australia (Reference number:
014036F) and all participants provided written informed consent.
Variances in eye sight meant that it was not possible to use a consistent strength of
magnifying lens in the magnified condition as the view of the thigh would not be in
focus for some of the subjects. The testing position and strength of magnifying
glasses was therefore slightly variable between subjects. The strength of the
magnifying glasses ranged from +1.5 to +3.5. The strongest magnification possible
was used whilst still maintaining clear focus of the thigh. The process to establish the
appropriate glasses strength and thigh position will be explained in detail in the
“Establishing the testing position” section below.

4.1.1 Participants.
A cohort of 20 healthy individuals were recruited using a general email advert and a
snowball sampling technique of the students and staff of The University of Notre
Dame Australia. Due to the fact that some of the subjects were current students of
the School of Physiotherapy, there was the possibility of bias being an issue. To
mitigate this problem, the author ensured that none of the subjects were her current
students, and each participant was clearly advised that they may withdraw at any
stage of the study with no consequences.
Inclusion criteria for the primary study were identical to those of the pilot: aged
between 18 and 50 years, proficient in written and spoken English and the ability to
provide informed written consent. Participants were excluded if they suffered
ongoing lumbar spine problems, experienced abnormal tenderness to palpation of
the soft tissues of the thigh, presented with reduced or excessive knee or hip
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movement, had suffered leg pain that required a visit to a health care professional
within the previous 12 months or had sustained a fracture or dislocation of the leg
within the last five years. They were also excluded if they had any ongoing medical or
neurological conditions, consumed regular anticoagulant medication or medications
known to influence pain sensitivity (e.g. painkillers, anti-inflammatories, antidepressants) or if they had recently trained the quadriceps with eccentric strength
exercises (within the previous six months). An exclusion criterion unique to the
primary study was any participant who required glasses to obtain normal vision. The
magnified condition in the primary study was established by fitting the subject with
a pair of magnifying glasses. This would have been physically impossible to do if they
were already wearing glasses. Wearing contact lenses at the time of testing was
acceptable as long as the subject had normal vision with the lenses in situ.

4.1.2 Experimental procedure.
Each participant attended two sessions, 48 hours apart.

Session one.
The purpose of the first session was to obtain subject demographics, to establish a
suitable test position for the 2nd session for each subject, to complete two
questionnaires and to guide subjects through an exercise protocol aimed at inducing
DOMS.
On arrival, subjects received a Plain Language Statement, written informed consent
was obtained and basic demographic information collected. The procedure of the
study was explained to the subjects and they were asked to complete the short-form
Pain Anxiety Symptoms Scale (PASS-20) questionnaire (see Appendix 1) and the Pain
Sensitivity Questionnaire (PSQ) (see Appendix 2). The researchers felt it would be
worthwhile to explore for any interaction between pain anxiety, trait sensitivity and
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pain during the various visual conditions, hence the inclusion of these questionnaires.
Thereafter the subject’s maximal isometric knee extension strength was assessed and
the test position established in preparation for the 2 nd session. Finally the subjects
underwent the exercise protocol aimed at inducing DOMS.

4.1.2i Maximal isometric knee extension strength.
The assessor used a hand-held dynamometer to establish the maximum force each
participant could generate with an isometric quadriceps contraction. This process
was identical to that done in the pilot study- performed in a seated position, with the
knee extended to 10⁰ off full extension. The subject was instructed to extend the
knee maximally against the resistance of the dynamometer until the “beep” sound
was heard. The maximum force generated during the contraction was recorded on
the dynamometer and documented. This was repeated three times for consistency
and the average score used to calculate the amount of resistance required during the
testing session (see 4.1.3vii Testing procedure)

4.1.2ii Establishment of testing position.
During the first session the assessor sought to establish an appropriate test position
and the maximal magnification strength which could be used during the testing
process of the second session. Subjects were seated on a narrow desk, leaning back
comfortably against a wall for back support. Each subject donned the strongest
magnifying glasses (+3.5) and looked at their thigh to see if the thigh was in clear
focus. If not, they flexed their hip bringing their knee up towards their head. They
were instructed to stop at the point where the thigh came into focus. If the subject
was unable to focus clearly on the thigh at any point through their comfortable range
of hip flexion then the glasses with 0.5 less magnification strength was attempted
next. The same procedure was repeated until the subject was able to find an
appropriate pair of glasses and the exact position of their thigh to achieve clarity.
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Once the correct magnifying strength and thigh position had been established the
magnification strength and hip flexion angle was documented and used consistently
for all four visual conditions in the testing session. The angle of hip flexion ranged
between 90⁰ and 140⁰ between the subjects.

4.1.2iii Exercise protocol to induce DOMS.
The participant undertook exactly the same protocol as in the pilot study aimed at
inducing DOMS in the non-dominant quadriceps muscle group. They were closely
monitored and the movement was controlled by the researcher.

4.1.2iv PASS-20.
The PASS-20 consists of 20 items and measures fear and anxiety responses specific
to pain. Subjects were asked to circle one number from 0 which represents “never”
to 5 which represents “always” for each situation described. The total score out of
100 was established by calculating the sum of all the items. This questionnaire took
5-10 minutes to complete.

4.1.2vi PSQ.
The PSQ consists of 17 items. Each item describes a daily life situation and asks the
subject to rate how painful this would be for them on a scale of 0 to 10. There are
normally non-painful situations serving as sensory references interspersed between
a variety of types of painful situations e.g. hot, sharp etc. The PSQ-total score was
calculated as the average rating of items 1, 2, 3, 4, 6, 7, 8, 10, 11, 12, 14, 15, 16, and
17 (all but the three non-painful items). This questionnaire took between 5-10
minutes to complete.
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Plain language statements sent by email to subject prior to first session
↓
Arrival of subject at first session
↓
Procedure of session explained verbally
↓
Written consent obtained, demographics collected
↓
PASS-20 and PSQ questionnaires completed
↓
Maximum isometric quad strength at -10⁰ off full extension established
↓
Strength of magnifying glasses and test position established and documented
↓
Exercises completed
Figure 5. Flow diagram to represent sequence of events at subjects’ first visit.

Session two.
The 2nd session was attended 48 hours after the 1st session. The purpose of the 2nd
session was to determine the subject’s eligibility for continuation in the study,
establish the randomisation order of exposure for that subject to the four visual
conditions and then to perform the testing. Eligibility to participate was established
with the subject completing a previously validated Likert scale of delayed onset
muscle soreness.

4.1.2vi Likert scale.
At the 2nd session following the DOMS induction in session one, subjects completed
a previously validated Likert scale of delayed onset muscle soreness that recorded
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their perception of soreness they were experiencing at that moment in time. They
needed to score ≥ 3 and fulfil all other inclusion criteria to be included into the study
(see Appendix 4 for full data Collection template).

1

A light soreness in the muscle felt only when touched/ a vague
ache

2

A moderate soreness felt only when touched/ a slight persistent
pain

3

A light muscle soreness while walking up and down stairs

4

A light muscle soreness when walking on a flat surface

5

A moderate muscle soreness, stiffness or weakness while walking

6

A severe muscle soreness, stiffness or weakness that limits my
ability to move
Figure 6. Modified Likert Scale of muscle soreness.
(Andersen et al., 2008).

4.1.2vii randomisation of exposure to visual conditions.
Eligible subjects were assigned the next participant number and this was recorded on
the data capture sheet. They were asked to open the particular sealed envelope
which corresponded to the participant number they had been assigned. Inside was a
letter: A, B, C or D which matched one of four particular sequences of order of
exposure to the visual conditions. The letters had been randomly generated by
computer using Excel software and the four sequences had been derived using a Latin
Square design. Once the order of exposure to the visual conditions had been
established the testing procedure began.
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4.1.2viii Testing procedure: evoked pain during DOMS.
Testing was performed at the 2nd session 48 hours after the 1st session. The testing
involved the subject performing quadriceps contractions under load at 15 minute
intervals, under various visual conditions and rating the pain evoked by these
standardised contractions. This process was completed at the 15 minute mark, 30
minute mark, 45 minute mark and 60 minute mark.
The four visual conditions we investigated were:


Visualisation of the thigh without visual manipulation



Visualisation of the thigh with magnifying glasses



Visualisation of the contralateral thigh



Visualisation of a neutral object

“Visualisation of the thigh without visual manipulation” involved the subject merely
observing the mid-thigh of the affected leg, positioned in their pre-established testing
position. A sandbag was fitted to the distal tibia at the start of the fixation period.
The load of the sandbag was standardised by calculating 40% of the average force
recorded during the maximal isometric contractions completed during session one,
48 hours previously. This was attached to the distal tibia using a Velcro strap at the
commencement of each fixation period and only removed at the start of the washout
period. The same sandbag was used for each of the four conditions.
“Visualisation of the thigh with magnifying glasses” was the condition used to create
the magnified image of the affected thigh. Again, subjects observed the mid-thigh of
the affected leg, but this time they observed the thigh through magnifying glasses.
On completion of the testing process during the magnified condition, subjects were
asked to rate the degree of magnification they were experiencing while wearing the
glasses using the “Scale of perceived enlargement”, prior to the sandbag being
removed for the wash-out period.
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“Visualisation of the contralateral thigh” involved the subjects observing the midthigh of the unaffected limb while the subject was still set up in the testing position.
The affected limb was hidden from view by a box that was fitted over it. The box was
also covered by a towel to ensure no visualisation of the affected thigh.
The final condition, “Visualisation of a neutral object”, made use of a box as the
neutral object. A box was placed over the affected thigh to hide the view of the thigh.
The limb was maintained in the identical set-up position and the sandbag was fitted
to the distal tibia throughout the fixation and testing procedure as per the other three
conditions. The subject was asked to focus on the box for that condition.
The fixation period lasted five minutes and was aimed at allowing the subject to adapt
to the new visual condition. Following this period, the subjects performed the
quadriceps contractions against the load of the sandbag. The researcher passively
extended the affected knee joint. From this position the subject was verbally guided
to perform a controlled lowering of the foot towards the floor, allowing flexion of the
knee toward 90° over the period of 3 seconds. This movement required an eccentric
lengthening contraction of the DOMS-affected quadriceps muscle. This procedure
was repeated three times and between each of the three repetitions the assessor
extended the knee passively, returning it to the starting position of full knee
extension. Pain was rated using an 11-point numerical rating scale (NRS) with 0
reflecting no perceived pain and 10 reflecting the worst possible pain. Pain was rated
by the participant immediately following each standard contraction. After three
contractions the sandbag was removed and the subjects were given a five minute
washout period. This process was repeated for all four visual conditions.
If the subject rated their pain consistently as zero out of ten on the NRS, then the
subject was excluded from the study.
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a)

b)

c)

d)

Figure 7. The four visual conditions.
This figure illustrates the four visual conditions we investigated; namely the effect of a)
normal vision b) magnified condition c) vision of contralateral thigh d) vision of neutral object
on the perceived level of pain.
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4.1.3viii Scale of perceived enlargement.
Varying strengths of magnifying glasses had to be used to accommodate for
differences in people’s eyesight. Following the eccentric contractions performed with
the magnifying glasses on, to ensure that visual manipulation of leg size by the glasses
had been effective, the subjects estimated the effect of the glasses using a nine-point
scale. The subjects were asked to rate the degree of magnification they perceived
prior to removing the glasses, using the following scale:

-4

-3

-2

-1

Extremely
shrunken

0

1

Normal
size

2

3

4
Extremely
enlarged

Figure 8. Scale of Perceived Enlargement.
This scale was used by the subjects during the magnified condition to estimate the effect of
magnification induced by wearing the glasses.
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Subject scored pain according to Modified Likert Scale (appendix 3)
↓

↓

Score ≥ 3

Score < 3

↓

↓

Included in study

Excluded from study

↓
Participant number allocated
↓
Corresponding
revealed

sealed envelope

opened and sequence of visual conditions

↓
Start of exposure to visual condition
Sandbag strapped around distal tibia
↓
5′ fixation period to visual condition
↓
3 submaximal eccentric repetitions performed
↓
Subject scores each contraction /10 on NRS
↓
(Estimation of perceived magnification of thigh using 9-point scale for magnification
condition only)
↓
Sandbag removed for washout period
↓
Process repeated from Start of exposure to visual condition
for next visual condition

Figure 9. Flow diagram to represent sequence of events at subjects’ second visit.
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4.2

Data Analysis
4.2.1 Sample size calculation.

Based on data from the pilot study, the within-subject difference in means in pain
intensity ratings (NRS) over the hour was estimated to be 0.3 and this was used as
the threshold for determining the minimal detectable change in the power
calculation for the primary study. The power of a four phase cross-over design using
a minimal detectable difference of 0.3 achieved 90% power when a minimum of 17
subjects were recruited, the standard deviation of the mean differences was 0.34 and
the significance level was set at 0.05. We oversampled by three subjects in the
primary study to give a total sample of 20 subjects which increased the power to 96%.

Power vs N by D1 with D0=0.000 Sd=0.340 Alpha=0.05 T
Test
1.2

0.300

0.8

D1

Power

1.0

0.400

0.6

0.500
0.4

0.2
0

10

20

30

40

50

N

Figure 10. Graph to establish sample size required in Primary Study.
This graph gives the sample size for three different values of the mean difference and the
impact on Power (0.3, 0.4 and 0.5). A sample size of 20 retains a power of greater than 80%
in all three cases.
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4.2.2 Exploration of the data and tests for normality.
Descriptive statistics were used to present demographic data, pain ratings for each
experimental condition and results from the PASS-20 and PSQ. Normality of
distribution was assessed by visual inspection of Q-Q plots and further investigated
with Shapiro-Wilk tests for normality. All results were reported as Mean ± SD. A p
value of <.05 was considered to represent statistical significance. All data were
analysed using IBM SPSS Statistics 23.0 software.

4.2.3 Methodological checks.

4.2.3i Effectiveness of the glasses used to magnify the image of the thigh.
Descriptive statistics were used to report the results of the nine-point scale to
establish the effectiveness of the glasses used to produce an enlarged image of the
affected thigh during the “magnified” condition. A score of 0 would indicate that the
thigh is perceived as being the same size as normal, with increasing positive scores
indicating increasing degrees of perceived enlargement.

4.2.3ii Exploration of potential confounding variables.

The effects of co-variates on the primary dependent variable were analysed using a
general linear model (repeated measures) with the relevant covariate included. Age,
trait pain sensitivity (PSQ) and trait pain anxiety (PASS-20) were treated as covariates
within the model whilst gender and order effect were treated as between-subject
factors.
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4.2.4 Hypothesis testing.

4.2.4i Effects of vision on pain perception.

A general linear model (repeated measures) was used to test the primary hypotheses.
Pain intensity rating was the dependent variable and the visual condition was the
independent variable with four levels (neutral object, visualisation of contralateral
thigh, normal visualisation of thigh, magnified visualisation of thigh). Covariates and
between-subject factors found to be statistically significant were adjusted for in the
overall general linear model test.

4.3

Results
4.3.1 Exploration of the data and tests for normality.

A total of 22 subjects were recruited from staff and students at The University of
Notre Dame Australia. One participant was excluded at the start on the first session
as he did not meet the inclusion criteria (he was taking regular analgesia for cervical
spine-related pain). A second was excluded at the end of the second session as he
recorded no pain with any eccentric contraction during any of the experimental
conditions. Twenty participants met all inclusion criteria and were included in the
analyses. All participants completed all experimental conditions and there were no
missing data.
Of the 20 participants 8 were male and 12 female. The average age was 26.45 years
± 7.0 with a range from 20 to 47 years. The average PSQ score was 2.58 ± 0.76. This
score would be classified as a low trait sensitivity score (Kim et al., 2015). The average
PASS-20 scores for our study was 17 ± 15.14. Again, this would be classified as a low
pain-related anxiety score (Abrams, Carleton, & Asmundson, 2007).
At the start of the second session the average score on the Modified Likert scale
representing pain intensity during the previous 24 hours was 3.9 ± 0.54, with a range
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of 3 (the minimum entry criteria) to 5. This meant that every participant was eligible
to continue with the testing procedure and could be included in the study.
Shapiro-Wilks tests for normality demonstrated the majority of the data was not
normally distributed and there were several outliers across three out of the four
conditions. In order to meet the assumptions behind the general linear model
(repeated measures) the data were log-transformed. All further analysis of the
primary dependent variable was performed on this new log-transformed data. Logtransformation resulted in the majority of the data being normally distributed
(Shapiro-Wilks test p >0.05) and a significant loss of outliers (only one outlier for one
condition).

4.3.2 Methodological Checks.
4.3.2i Effectiveness of the glasses used to magnify the image of the thigh.

The average “Effect of Magnification” questionnaire score was 1.8 ± 0.6, with a
minimum value of 1.0 and a maximum value of 3.0, indicating the glasses to be
effective in producing an enlarged image of the thigh. A score of 0 would indicate
that the thigh is perceived as being the same size as normal, with increasing positive
scores indicating increasing degrees of perceived enlargement.

4.3.2ii Exploration of potential confounding variables.

Age, PSQ and PASS-20 were individually included as covariates in the general linear
model (repeated measures). All analysis demonstrated that assumptions of sphericity
were met. There was no significant interaction between the condition and age,
(F=.357(3,54), p=.784). Analysis of PSQ and condition demonstrated no interaction
(F=1.596

(3,54),

p=.201). Lastly, PASS-20 and condition similarly demonstrated no

interaction (F=1.331 (3,54), p=.274).
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Gender and order effect were explored as between-subject factors in the general
linear model (repeated measures). There was no interaction between gender and
condition (F=0.098 (3,54), p=.961). A main effect for order by condition was found
(F=2.111 (9,48), p=.047) however post-hoc pair-wise comparisons were not statistically
significant (p>0.05 for all comparisons).

4.3.3 Hypothesis testing.
4.3.3i Effect of vision on pain perception.

The mean pain intensity reported under each of the visual conditions can be found in
Table 2. To determine if pain intensity varied between the visual conditions a general
linear model (repeated measures) on the log-transformed data across all four visual
conditions was used. As there was no evidence of an interaction between order, age,
gender, PASS-20 or PSQ and condition, treatment effects were estimated unadjusted
for these factors. A significant main effect of visual condition on pain score (NRS) was
found (F=2.797

(3,57),

p=.048). However Bonferroni corrected post-hoc pairwise

comparisons demonstrated no significant difference between any conditions,
indicating that pain intensity was not significantly influenced by visual condition. We
therefore accept the null hypothesis that vision and visual distortion of size in the
form of magnification have no significant effect on the intensity of perceived
experimental deep tissue pain.
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Condition

Mean ± SD

Neutral object

2.68 ± 1.16

Contralateral thigh

2.73 ± 1.48

Normal vision of thigh

2.60 ± 1.65

Magnified view of thigh

3.05 ± 1.57

Table 2. Mean and Standard Deviations of NRS pain scores across the four conditions.
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4.4

Discussion
4.4.1 Summary of main findings.

The aim of this project was to examine whether visualisation of the painful body part
has an effect on experimental deep tissue pain in a healthy population. Secondly, we
set out to determine if visual distortion of size, in the form of magnification, had a
further effect on the perceived pain.
Recent studies investigating visual analgesia in response to observation of a
superficial noxious stimulus led to the first hypothesis: that visualisation of the
painful body part could influence deep tissue pain. Since results of these studies have
been mixed the direction of the effect could not be predicted with confidence.
Studies investigating the effect of visual distortion of size on perceived pain in both
clinical and non-clinical populations have also reported contrasting results. Our study
aimed to establish the effect of magnification of the painful viewed body part on deep
tissue pain in a healthy population. We hypothesised that visual magnification would
produce an effect on the intensity of perceived pain, again without being able to
predict the direction of the effect.
Contrary to our first hypothesis we found that direct visualisation of the painful body
part, which in this case was the anterior thigh, had no significant effect on pain
intensity ratings of experimental deep tissue pain. Furthermore, visual distortion of
size in the form of magnification had no significant effect on perceived pain levels in
a healthy population.
When we explored for potential confounding variables, the covariates of age, pain
sensitivity and trait anxiety did not demonstrate any significant interactions with the
visual conditions and neither did gender and order effect when explored as betweensubject factors.
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4.4.2 Relationship to existing literature.
This is a novel study. There are no similar studies against which our study can be
directly compared since no previous studies have investigated the effects of vision
and visual distortion of size on experimental, deep tissue pain. Our hypotheses were
based on the findings of experiments involving noxious stimuli applied cutaneously
to induce experimental, superficial pain in healthy subjects and on studies involving
clinical populations. Significant differences appear to exist between the underlying
mechanisms and the presentation of superficial and deep pain. With this in mind, we
anticipated but could not confidently predict a visual analgesic effect on deep tissue
pain. In our study vision had no effect on perceived pain.
Our findings contradict those of Longo et al. (2009), who demonstrated an analgesic
effect of visualisation on superficially-induced experimental pain in a healthy
population. Although both studies involved experimental pain, a major difference
between the two studies is that our study involved noxious stimulation of deep tissue
while that of Longo et al. (2009) involved superficial stimulation. It is possible that the
analgesic effect to visualisation observed when the cutaneous tissues were
stimulated is optimised as the tissues being stimulated are directly observable and
visualisation could reduce the threat value of the pain by providing the individual with
information that all is well with the stimulated tissue. This is in contrast to deep tissue
stimulation where only the overlying skin can be observed however the actual tissue
affected cannot be visualised directly so adding visual input would not have
significant informative value in terms of perception of safety of the stimulated
structure. A further important difference is the different method of visualisation
employed in the two studies. It has been proposed that the visual analgesic effects
observed in the experiment by Longo et al. (2009) may be more as a result of viewing
a reflected image than due to the effects of vision (Torta et al., 2015). Torta et al.
(2015) investigated their proposal by comparing pain intensity ratings of superficial
noxious stimuli with subjects observing their hand directly, an illusion of their hand
via the use of a mirror-box and a neutral object. There were no significant differences
noted across the different conditions and no visual analgesia was observed under any
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of the conditions. Our findings would tend to support those of Torta et al. (2015) as
our study excluded the use of a mirror box and no effect was observed.
Our findings also support some of the observations of Valentini et al. (2015), who did
not observe a visual analgesic effect when the hand was situated on the normal side
of the body. They only found visual analgesia of experimental, superficial pain to exist
when the limb was placed on the contralateral side of the midline. In our current
study, we did not explore the effects of vision coupled with crossing the midline on
deep tissue pain, but our results concur in that we did not observe visual analgesia
when the limb was observed in its regular ipsilateral position.
When we compare our study to those which investigate the effects of vision in clinical
populations, our results differ. Both Wand et al. (2012) and Diers et al. (2015)
observed analgesic effects with vision of the back in chronic back pain sufferers.
Wand et al. (2012) made use of a mirror to allow subjects to view their backs, while
Diers et al. (2015) used real-time video feedback. Perhaps the mechanism driving
the effects observed in both these experiments was similar to that underlying the
observations in the experiments which used a mirror-box (that of possible conflict
between the somatosensory, visual and proprioceptive representations requiring
higher cognitive processing levels with resultant pain inhibition). Our study made use
of direct visualisation i.e. no reflected images were generated and no analgesic effect
was observed. An alternative and very plausible explanation for the positive findings
in response to visualisation may be due to the particular part of the body which is
involved. In both these studies the part visualised i.e. the back, is a region of the body
which is not readily visible to the subject. It was evident that the introduction of visual
feedback from the back region made a significant difference to the perceived pain
intensity. In our study, the affected body part is body part that is usually visible to the
subject so the novelty and additional information provided by visualisation would
have been minimal.
With regards to our second hypothesis proposing that visual magnification of a
painful body part would induce an effect on pain, the results of this study differ from
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Mancini et al. (2011) upon which the hypothesis was formulated. Our study found no
significant effect of the visual magnification condition although Mancini et al. (2011)
did note an analgesic effect. A major difference between the two studies is that
Mancini et al. (2011) employed a topical noxious stimulus which induced superficial
pain, while our study involved deep tissue stimulation. The linear relationship
between pain perception and visual magnification that was demonstrated by Mancini
et al. (2011) was less consistently demonstrated by Osumi et al. (2014) in that only
the subjects who displayed more vivid tactile perception demonstrated an increase
in pain thresholds to the magnified condition (the “high” threshold group). The “low”
threshold group, demonstrating a lower pain threshold, displayed a negative
emotional response to the enlarged view and no TPD change. Again, the pain induced
in this experiment was perceived superficially. These findings contrast those in our
present study where no analgesia nor any effect of magnification was observed.
Mancini et al. (2011) and Osumi et al. (2014) both made use of mirror-boxes to
enlarge the view of the limb and this variance in methodology could be a contributing
factor to the different results obtained between the studies, as has been suggested
by Torta et al. (2015). An alternative explanation is that superficial pain mechanisms
vary from deep pain mechanisms and that researchers and clinicians should avoid
extending the results of studies involving superficial experimental pain to
experimental deep pain or clinical pain presentations (S. Mense, 2003; Uematsu et
al., 2011; Witting et al., 2000). The question remains whether findings of studies such
as ours (involving experimental deep tissue pain) can be generalised to clinical
chronic pain presentations.
Moseley et al. (2008) found a significant effect of visual distortion of size in a CRPS
population. Minification and magnification using binoculars reduced and augmented
the pain respectively. The findings of Ramachandran et al. (2009) tend to support this
in a phantom limb pain population. Visual analgesia was demonstrated using a
mirror-box, and although no effect was observed in the magnified condition, there
was a significant analgesic effect with minification. These findings contrast the results
of the experiments by Mancini et al. (2011) and ourselves. This may highlight the
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difference between experimental and clinical pain presentations but it could also
exist because CRPS and phantom limb pain are unique and extreme chronic pain
experiences in which the visual appearance of the painful area is greatly disrupted
(Birklein, Riedl, Claus, & Neundörfer, 1998; Harden et al., 1999) and visual
manipulation, particularly in the form of normalisation, is likely to have a powerful
threat-reducing effect.
The PASS-20 is a brief version of the original PASS-40 and has been shown to be a
good reflection of the PASS-40 (Roelofs et al., 2004). Both these measures assess four
distinct components of pain anxiety: cognitive anxiety (catastrophic thinking), fearful
thinking about pain and anticipated negative consequences related to pain, escape
and avoidance behaviour, and physiological anxiety (heightened arousal) (Watt,
Stewart, Moon, & Terry, 2010). If desired, subscale scores for these components can
be determined by summing particular items in the questionnaire together for each
component of pain anxiety. In this study we were more interested in a general pain
anxiety score so we used the total scores for our analyses. During the “neutral object”
visual condition of the present study, the subject’s view of their painful thigh was
obstructed by the box. This could have potentially reduced the level of perceived
control the subject had over their painful body part and induced a measure of
subsequent fear or heightened anticipation of pain (one of the components of pain
anxiety). Pain anxiety has been found to be associated with augmented pain
perception (L. M. McCracken & Gross, 1998) however our results did not
demonstrate a significant interaction between the PASS-20 scores and the pain
scores during the “neutral object” visual condition. In previous studies, the majority
of individuals classified as having “high” pain-related anxiety have been shown to
have PASS-20 total scores greater than 30 (Abrams et al., 2007). The average PASS20 scores for our study was 17 ± 15.14, which is well below that threshold. It should
be noted, however, that the population involved in this experiment was a collection
of physiotherapy students who had received education in the mechanisms underlying
pain perception, and thus were likely to present with relatively lower pain anxiety
levels than the general public.
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When we explored for possible interactions between trait pain sensitivity (reflected
by the PSQ questionnaire) and the reported pain scores during the various visual
conditions no significance was apparent. There have been significant correlations
reported between PSQ scores and experimental pain intensity ratings in healthy
subjects (Ruscheweyh et al., 2009). PSQ scores have also been reported to be
significantly associated with pain anxiety and fear scores (Nelson & Massey, 2013).
With no significant pain intensity ratings being observed across any of the visual
conditions in the current study, and no interactions demonstrated between trait
anxiety and pain scores, we did not expect to observe a significant finding between
the pain sensitivity and the pain scores across any of the visual conditions either. Our
results confirmed our expectations.

4.4.3 Clinical implications and contributions.
This thesis makes an original contribution to knowledge as no previous studies have
investigated the modulatory effects of visualisation or visual magnification on deep,
experimental pain. These effects have previously been explored in experimental
superficial pain and clinical populations although it has remained unclear whether we
could extrapolate the results of previous studies to acute deep tissue pain. Previous
studies have also yielded contrasting effects making it difficult to predict with
confidence the direction of the effects on deep tissue pain. As highlighted in the
previous section (section 4.4.2) various hypotheses could explain the results of each
of those studies. Combining the findings of previous research and those in our study
some common themes start to evolve which appear to be able to consistently explain
the various findings.
Clinical populations in which visualisation and visual distortion of size have had an
effect appear to be those in which the condition involves significant visible physical
changes to the affected area. In a CRPS population, such as that researched by
Moseley et al. (2008), changes in the subjects’ hair and nail growth can be seen, as
well as swelling, excessive sweating or dry skin. In a phantom limb pain patient such
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as that studied by Ramachandran et al. (2009), there is a significant visual change
with the absence of a limb. The introduction of visual feedback would have allowed
subjects to normalise the perceived appearance of their limb and this is likely to have
reduced fear associated with the pain contributing to the analgesic effects observed.
Our study involved experimental pain in the form of DOMS. DOMS is likely to have
been experienced regularly by our cohort of healthy subjects in the past. Ethically,
we were obliged to disclose that the type of pain induced was merely a transient pain.
These factors would have contributed to the lack of threat associated with the DOMS
pain inflicted on them. Furthermore there were no physical changes or observable
abnormalities associated with the pain induced in the subjects, so the impact of visual
input would have been minimal compared to the visual input which normalised the
CRPS or phantom limb subjects’ perception of their limb appearance. This would help
to explain our negative findings.
It appears that visual analgesia also depends on the body part affected. If a body part
is usually not visible to the subject then visual feedback is likely to have a greater
impact than visualisation of a body part that is usually readily visible. Supporting this
proposal, would be the findings of Wand et al. (2012) and Diers et al. (2015) who
demonstrated analgesic responses in chronic back pain patients with the subject’s
visualisation of their backs. Although there may not be visible changes to the
appearance of the back, the back is a region of the body which is not readily visible
to the subject and the introduction of visual feedback from this region is likely to have
provided participants with information about the state of their back that is not
normally accessible to them. Our study indirectly supports this notion too. We can
usually see our anterior thigh easily so adding visual feedback doesn’t add
information or reduce the threat value of the perceived pain.
That Longo et al. (2009) and Mancini et al. (2011) observed analgesic effects of
visualisation and visual distortion of size respectively, of readily observable body
parts such as the hand, may be explained by the fact that the pain induced in their
studies was topical. Visualisation would have enhanced the subjects’ sense of safety
by relieving any fears of injury resulting from the perceived noxious stimulus, and in
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turn inducing an analgesic effect. This proposal would also explain the lack of effect
observed in our present study. The pain induced was deep tissue pain. The tissues
affected were not directly observable so there was not the same sense of safety and
control to be gained as there was by observing topical pain. Furthermore, research
suggests that the nature and underlying mechanisms of topical pain and deep tissue
pain differ significantly (S. Mense, 2003; Uematsu et al., 2011; Witting et al., 2000).
As a result one should not automatically expect a common modulatory phenomenon
to exist for both types of pain.
The main aim of this study was to explore the mechanisms underlying deep
experimental pain. The priority was not to source new treatment options, although
favourable findings to visualisation or visual magnification may have informed future
treatment. From a clinical perspective, it appears that “direct” visualisation and
“direct” visual magnification may not be useful for acute pain management programs
in the case of pain perceived in body parts that are readily observable. Visualisation
is more likely to have a greater impact on body parts which cannot usually be seen
such as the lower back. This hypothesis would be supported by the results observed
by Wand et al. (2012) and Diers et al. (2015). The likely mechanism underlying this
analgesia is the “de-threatening” effect that visual input would have on a body part
that cannot usually be seen. Also, from a clinical perspective, visual analgesia is likely
only to exist for pain which associated with altered body perception or physical
changes to the appearance of that body part, as observed by Ramachandran et al.
(2009), Moseley et al. (2008) and Preston and Newport (2011). All these studies
manipulated the visual feedback serving to normalise the perception of that body
part and in so doing maybe increase the sense of safety and provide evidence that all
is well with that body part and consequently modulate the pain experience.
Visualisation is unlikely to have any impact on pain whereby the overall appearance
of the body part remains normal. This notion is supported by the results of Torta et
al. (2015) and by our study.
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CHAPTER FIVE: LIMITATIONS, RECOMMENDATIONS AND
CONCLUSION

5.1

Limitations

Ethically, there is a limitation to the amount of pain that can be inflicted on or induced
in subjects, and by the ways in which this pain can be induced. A widely used means
of inducing transient, endogenous experimental pain is via the DOMS phenomenon.
It induces an acceptable level of pain, although the pain level may be below those
pain levels experienced by the clinical population, especially those with chronic pain.
Also, the pain induced is experimental. Ideally, studying a clinical population would
be more relevant but it is very difficult to standardise subjects and testing procedures
as clinical pain states vary significantly from one individual to the next. The necessary
constraints to ensure internal validity of the research would limit sample size. These
limitations led to the decision to induce DOMS to represent deep tissue pain.
Recognising that we cannot completely apply the results to clinical pain, the study
does serve to give us a better understanding of the behaviour and mechanisms
underlying deep tissue pain, which may be beneficial.

One should consider the type of pain that was induced, the effect that our belief
systems have on our pain perception and the potential effect this could have on visual
analgesia. The majority of the population recruited for this study were physiotherapy
students. These subjects are likely to have a greater interest in physical activity and
hence have been exposed to DOMS of the lower limbs more frequently than a regular
population. This frequent exposure to DOMS is likely to have reduced any painassociated fear. Through their curriculum the students are likely to have developed a
comprehensive understanding of pain mechanisms. Understanding their pain would
further minimise their fear. It is probable that a reduction of the fear/ threat value
associated with the pain would reduce perceived pain levels. It was imperative,
therefore, to include the modified Likert scale to ensure that the subjects were
experiencing adequate pain levels prior to the testing procedure.
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5.2

Recommendations

“Direct” visualisation alone did not influence pain rating in our study, however
several studies involving experimental superficial pain (Longo et al., 2009; Mancini et
al., 2011; Osumi et al., 2014) and those involving clinical pain populations (Moseley
et al., 2008; Ramachandran et al., 2009) have noted visual analgesic effects using
“indirect visualisation” (albeit in opposing directions). Use of a mirror-box has
allowed this “indirect visualisation”. With this in mind, it may be worthwhile exploring
whether a mirror-box has any effect on deep tissue pain. Researchers would need to
be mindful that if DOMS is to be used as the experimental deep tissue pain, a muscle
group needs to be chosen that is both easily visible by the subject (for example, the
gastrocnemius is difficult to observe due to its dorsal location) and easy to situate
alongside a mirror to induce an illusion. If an effect is noted while using the mirror
box, it could be likely that the mechanism underlying this effect involves the
introduction of a degree of conflict between visual, sensory and proprioceptive
representations which requires augmented cognition to decipher, in turn affecting
and inhibiting perceived pain levels. Depending on the direction of the effect, the
mirror box could potentially be incorporated as a useful clinical tool for managing
clinical pain.
Our study was initiated prior to the publication of findings of Valentini et al. (2015)
and Osumi et al. (2014), who have not been able to reproduce the consistent visual
analgesic results observed by Longo et al. (2009) and Mancini et al. (2011). Valentini
et al. (2015) did not use a mirror-box and could only get an analgesic effect with vision
of the body part when it was combined with the affected limb crossing the midline.
Taking this into account, it may also be worthwhile to include a “crossed midline
condition” as another visual condition to the experiment suggested above.
To explore visual analgesia in experimental, deep tissue pain, another study involving
the use of real-time video feedback to produce an image of the affected body part,
would be informative. Real-time video feedback has successfully induced visual
analgesia in clinical populations studied by Diers et al. (2015) and Preston and
Newport (2011). It has the potential to be a very practical treatment modality. It
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could be used on all parts of the body (unlike the mirror- box) and would not involve
the subjects crossing the midline (which is difficult to achieve with some body parts).
The image could also be easily manipulated to increase or decrease the size of the
viewed body part in order to normalise the subjects’ perception of their limb size if
these are found to be helpful.
Combining the findings of our current studies and other relevant research it is
apparent that visualisation may only have a modulatory effect on pain when visual
feedback offers a significant contribution to the generation or maintenance of
perceived pain; in pain associated with visible changes to the affected tissues (or
perceived to have physical changes in appearance), pain perceived in tissues which
are directly visible (such as the skin as opposed to deeper tissues) or pain perceived
in body parts that are not readily visible (such as the lumbar spine). With this in mind,
it would be worthwhile inducing experimental deep tissue pain in healthy volunteers
in a body part that is not readily visible, such as the back, buttock or hamstring
regions, and exploring the effects of visualisation on the perceived pain intensity, in
order to substantiate the proposal that visualisation has a modulatory effect only
when the visual input, or lack thereof, plays a significant role in the generation or
maintenance of pain.
It would be also be worthwhile observing the effects of visual manipulation in a
population of chronic pain sufferers involving body parts that are readily visible and
that do not involve noticeable physical changes to the body part, but are perceived
to have physical changes in appearance, that is the subject has a dysfunctional
cortical representation of that body part. It would be interesting to establish whether
normalising their perception via visual feedback has an impact on pain. Subsequent
to the writing of this literature review a recent and relevant study has been published.
Healthy subjects demonstrated physiological changes in the form of skin conductance
response (SCR) to topical painful stimuli with the simultaneous use of embodied
virtual images of the affected body part. SCR is reflective of the autonomic nervous
system’s response to painful stimuli. Typically, stronger responses of SCR are
observed for stimuli that are processed by the brain as more painful. The size of the
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embodied virtual image was manipulated and the changes in SCR were found to be
inversely proportional to the size of the image, as long as the image was believed to
be the subject’s own body. Besides affecting pain processing and subsequently the
SCR, the embodied virtual image did not result in any changes to the conscious
experience of pain, that is the pain intensity rating of this superficial, experimental
pain (Romano, Llobera, & Blanke, 2016). It may be worthwhile repeating a similar
experiment of virtual embodiment but this time with a population of chronic pain
sufferers in which the cortical representation of their affected part has been altered.
Virtual embodiment would be easier to implement than the traditional mirror-box
and the images could be easily manipulated to help normalise the subject’s
perception of their affected body part.
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5.3

Conclusion

The aim of the present experiment was to investigate, firstly, whether visualisation
of the painful body part has an effect on acute deep tissue pain in a healthy
population, and secondly, to determine if visual distortion of size, in the form of
magnification, has a further effect on the perceived pain, and if so, whether this is in
the direction of analgesia.
We found that visualisation of the painful body part had no significant effect on pain
intensity ratings of experimental deep tissue pain. Furthermore, there was no
significant effect of visual magnification on perceived pain levels.
The findings of this study have highlighted that experimental superficial,
experimental deep and chronic pain mechanisms appear to have different
modulatory factors. The results of our study together with the studies explored in
this literature review suggest that effects of visualisation and visual distortion of size
are likely to be limited to specific circumstances; when there are significant visual
changes to the appearance of a body part associated with the perceived pain or when
the pain is perceived in a body part that is not usually observed so visual feedback
has a major impact. We suggest that the augmented sense of safety and control that
visualisation introduces to topical pain explains the analgesic effect, contrasting the
lack of effect noted in our study involving “unobservable” deep tissue pain.
This study has contributed to a better understanding of the effects of visualisation as
a modulatory factor in acute deep tissue pain, however it is important to note that
only “direct” vision and “direct” visual magnification of the painful limb were tested
against control conditions. Conditions coupling visualisation with the use of a mirror
box, real-time video or subjects’ limbs crossing the midline were not explored.
Subsequent to the data collection for this study, it has become evident that these
factors could potentially contribute to visual analgesia. Further studies to investigate
the effects of these conditions coupled with visualisation or visual distortion of size
on deep tissue pain are warranted, as well as studies to explore the effects of
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visualisation on experimental deep tissue pain in body parts that are not readily
visible or clinical pain in which there is an altered cortical representation of that body
part.
Finally, as a result of this study, we can state with some confidence that acute deep
tissue pain appears not to be affected by “direct” visualisation or “direct” visual
magnification of the overlying skin of a body part which is usually readily observable.
We further recommend that it is not worthwhile including this in a management plan
for painful conditions of these regions.
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Appendix 1: PASS – 20
(Lance M. McCracken & Dhingra, 2002)
Individuals who experience pain develop different ways to respond to that pain. We
would like to know what you do and what you think about when in pain. Please use
the rating scale below to indicate how often you engage in each of the following
thoughts or activities.
Circle one number from 0 (NEVER) to 5 (ALWAYS) for each item.

1. I think that if my pain gets too severe, it will never decrease.
012345
2. When I feel pain, I am afraid that something terrible will happen.
012345
3. I go immediately to bed when I feel severe pain.
012345
4. I begin trembling when engaged in activity that increases pain.
012345
5. I can’t think straight when I am in pain.
012345
6. I will stop any activity as soon as I sense pain coming on.
012345
7. Pain seems to cause my heart to pound or race.
012345
8. As soon as pain comes on, I take medication to reduce it.
012345
9. When I feel pain, I think that I may be seriously ill.
012345
10. During painful episodes, it is difficult for me to think of anything else besides the pain.
012345
11. I avoid important activities when I hurt.
012345

103

12. When I sense pain I feel dizzy or faint.
012345
13. Pain sensations are terrifying.
012345
14. When I hurt I think about the pain constantly.
012345
15. Pain makes me nauseous (feel sick to my stomach).
012345
16. When pain comes on strong I think I might become paralysed or more disabled.
012345
17. I find it hard to concentrate when I hurt
012345

.

18. I find it difficult to calm my body down after periods of pain.
012345
19. I worry when I am in pain.
012345
20. I try to avoid activities that cause pain.
012345

Thank you for completing this questionnaire.
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Appendix 2: Pain Sensitivity Questionnaire
(Sellers, Ruscheweyh, Kelley, Ness, & Vetter, 2013)
This questionnaire contains a series of questions in which you should imagine
yourself in certain situations. You should then decide if these situations would be
painful for you and if yes, how painful they would be.
Let 0 stand for no pain; 1 is an only just noticeable pain and 10 the most severe pain
that you can imagine or consider possible.
Please mark the scale with a cross on the number that is most true for you. Keep in
mind that there are no ‘‘right” or ‘‘wrong” answers; only your personal assessment
of the situation counts. Please try as much as possible not to allow your fear or
aversion of the imagined situations affect your assessment of painfulness.

1. Imagine you bump your shin badly on a hard edge, for example, on the edge of a glass
coffee table.
How painful would that be for you?

0

1

2

3

4

5

6

not at all painful

7

8

9

10

most severe pain imaginable

2. Imagine you burn your tongue on a very hot drink. How painful would that be for you?

0

1

2

3

4

5

6

not at all painful

7

8

9

10

most severe pain imaginable
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3. Imagine your muscles are slightly sore as the result of physical activity. How painful would
that be for you?

0

1

2

3

4

5

6

not at all painful

7

8

9

10

most severe pain imaginable

4. Imagine you trap your finger in a drawer. How painful would that be for you?

0

1

2

3

4

5

6

not at all painful

7

8

9

10

most severe pain imaginable

5. Imagine you take a shower with lukewarm water. How painful would that be for you?

0

1

2

3

4

5

6

not at all painful

7

8

9

10

most severe pain imaginable

6. Imagine you have mild sunburn on your shoulders. How painful would that be for you?

0

1

2

3

4

5

6

not at all painful

7

8

9

10

most severe pain imaginable
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7. Imagine you grazed your knee falling off your bicycle. How painful would that be for you?

0

1

2

3

4

5

6

not at all painful

7

8

9

10

most severe pain imaginable

8. Imagine you accidentally bite your tongue or cheek badly while eating. How painful would
that be for you?

0

1

2

3

4

5

6

not at all painful

7

8

9

10

most severe pain imaginable

9. Imagine walking across a cool tiled floor with bare feet. How painful would that be for you?

0

1

2

3

4

5

6

not at all painful

7

8

9

10

most severe pain imaginable

10. Imagine you have a minor cut on your finger and inadvertently get lemon juice in the
wound.

0

1

2

3

4

5

6

not at all painful

7

8

9

10

most severe pain imaginable
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11. Imagine you prick your fingertip on the thorn of a rose. How painful would that be for
you?

0

1

2

3

4

5

6

not at all painful

7

8

9

10

most severe pain imaginable

12. Imagine you stick your bare hands into an esky filled with icy water for a couple of
minutes. How painful would that be for you?

0

1

2

3

4

5

6

not at all painful

7

8

9

10

most severe pain imaginable

13. Imagine you shake hands with someone who has a normal grip. How painful would that
be for you?

0

1

2

3

4

5

6

not at all painful

7

8

9

10

most severe pain imaginable

14. Imagine you shake hands with someone who has a very strong grip. How painful would
that be for you?

0

1

2

3

4

5

6

not at all painful

7

8

9

10

most severe pain imaginable

108

15. Imagine you pick up a hot pot by inadvertently grabbing its equally hot handles. How
painful would that be for you?

0

1

2

3

4

5

6

not at all painful

7

8

9

10

most severe pain imaginable

16. Imagine you are wearing sandals and someone with heavy boots steps on your foot. How
painful would that be for you?

0

1

2

3

4

5

6

not at all painful

7

8

9

10

most severe pain imaginable

17. Imagine you bump your elbow on the edge of a table
(‘‘funny bone”). How painful would that be for you?

0

1

2

3

4

5

6

not at all painful

7

8

9

10

most severe pain imaginable

18. Imagine you pick up a hot pot by inadvertently grabbing its equally hot handles. How
painful would that be for you?

0

1

2

3

4

5

6

not at all painful

7

8

9

10

most severe pain imaginable
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19. Imagine you are wearing sandals and someone with heavy boots steps on your foot. How
painful would that be for you?

0

1

2

3

4

5

6

not at all painful

7

8

9

10

most severe pain imaginable

20. Imagine you bump your elbow on the edge of a table (‘‘funny bone”). How painful would
that be for you?

0

1

2

3

4

5

6

not at all painful

7

8

9

10

most severe pain imaginable
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Appendix 3: Data Collection Pilot Study
SESSION 1:
Date: _________________________
Time: _________________________
Maximum isometric quadriceps contraction at -10 knee extension
Test 1
Test 2
Test 3
Average
40% of average

ACTION

SET 1

SET 2

SET 3

10 reps
30 sec rest
10 reps
30 sec rest
10 reps
2 min break
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SET 4

SET 5

SESSION 2:
Modified Likert Scale of muscle soreness (Andersen et al., 2008)
Date:
Time:
1

A light soreness in the muscle felt only when touched/ a vague
ache

2

A moderate soreness felt only when touched/ a slight persistent
pain

3

A light muscle soreness while walking up and down stairs

4

A light muscle soreness when walking on a flat surface

5

A moderate muscle soreness, stiffness or weakness while walking

6

A severe muscle soreness, stiffness or weakness that limits my
ability to move

Does subject fulfil inclusion criteria? __________________
Subject number: _________________________________

OUTCOMES:
(NRS pain score /10)
Date:

5 mins

Time:

Eccentric Quadriceps contraction NRS –test 1
Eccentric Quadriceps contraction NRS- test 2
Eccentric Quadriceps contraction NRS- test 3
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15 mins

25 mins

35 mins

Appendix 4: Data Collection Research Study
SESSION 1:
Date: _________________________
Time: _________________________
Maximum isometric quadriceps contraction at -10 knee extension
Test 1
Test 2
Test 3
Average
40% of average

Glasses magnification which allows focussed but magnified view of thigh: ___________
Position of leg for best focus Leg weights in situ: ________________________________

ACTION

SET 1

SET 2

SET 3

10 reps
30 sec rest
10 reps
30 sec rest
10 reps
2 min break
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SET 4

SET 5

SESSION 2:
Modified Likert Scale of muscle soreness (Andersen et al., 2008)
Date:
Time:
1

A light soreness in the muscle felt only when touched/ a vague ache

2

A moderate soreness felt only when touched/ a slight persistent pain

3

A light muscle soreness while walking up and down stairs

4

A light muscle soreness when walking on a flat surface

5

A moderate muscle soreness, stiffness or weakness while walking

6

A severe muscle soreness, stiffness or weakness that limits my ability
to move

Does subject fulfil inclusion criteria? __________________
Subject number: _________________________________
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OUTCOMES:
(NRS pain score /10)

Date:
Time:
VISUAL CONDITION - neutral object (X),
contralateral leg (CL), Normal (N), magnified (M)
Weights strapped around ankle
5 minute fixation time- subject to made aware that
they will need to estimate width of thigh after
fixation testing

Eccentric Quadriceps contraction NRS –test 1
Eccentric Quadriceps contraction NRS- test 2
Eccentric Quadriceps contraction NRS- test 3

“Effect of Magnification” Scale- done just prior to
removal of glasses in magnified condition
Weights removed from ankle prior to washout
period
5 minute washout period
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test 1

test 2

test 3

5 mins

15 mins 25 mins

test 4
35 mins

Appendix 5: Letter Granting Ethical Approval
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Glossary of Abbreviations
ACC

anterior cingulate cortex

AMPA receptors

α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid

ASQ

attribution style questionnaire

BAQ

Body Attitude Questionnaire

Ca2+

calcium ions

CGRP

Calcitonin Gene Related Peptide

CREB

cAMP response element-binding protein

CRPS

Chronic Regional Pain Syndrome

DLF

dorsolateral fasciculus

DLPFC

dorsolateral prefrontal cortex

DNIC

diffuse noxious inhibitory control system

DOMS

delayed onset muscle soreness

EEG

Electroencephalography

ERK

extracellular signal-related kinase

ERP

Event-related brain potential

FMRI

functional magnetic resonance imaging

GABA

gamma amino-butyric acid

IASP

International Association for the Study of Pain

IC

insular cortex

ICC

inter class correlation co-efficient

Minification

process of reducing something only in appearance, not in physical size

MEG

magnetoencephalography

Mg2+

magnesium ions
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NGC

nucleus reticularis gigantocellularis

NMDAR

N-methyl-D-aspartate receptor

NRM

nucleus raphe magnus

NWR

nociceptive withdrawal reflex

PAG

periaqueductal grey matter

PASS-20

pain anxiety symptoms scale questionnaire

PFC

prefrontal cortex

PKC

protein kinase-C

PPC

posterior parietal cortices

PPI

perceived pain intensity

RVM

rostral ventromedial medulla

S1

somatosensory cortex

S2

secondary somatosensory cortex

SCR

Skin conductance response

TENS

transcutaneous electrical nerve stimulation

TRP

transient receptor potential

VAS

visual analogue scale

VPL

ventroposteriolateral nucleus
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